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ABSTRACT 42 
Introduction: Low- and middle-income countries (LMICs) are crucial in the global response to 43 
antimicrobial resistance (AMR), but diverse health systems, healthcare practices, and cultural 44 
conceptions of medicine can complicate global education and awareness-raising campaigns. Social 45 
research can help understand LMIC contexts but remains underrepresented in AMR research. 46 
Objective: To (1) describe antibiotic-related knowledge, attitudes, and practices of the general 47 
population in two LMICs and to (2) assess the role of antibiotic-related knowledge and attitudes on 48 
antibiotic access from different types of healthcare providers. 49 
Design: Observational study: cross-sectional rural health behaviour survey, representative on the 50 
population level. 51 
Setting: General rural population in Chiang Rai (Thailand) and Salavan (Lao PDR), surveyed between 52 
November 2017 and May 2018. 53 
Participants: 2141 adult members (≥18 years) of the general rural population, representing 712,000 54 
villagers. 55 
Outcome measures: Antibiotic-related knowledge, attitudes, and practices across sites and healthcare 56 
access channels. 57 
Findings: Villagers were aware of antibiotics (Chiang Rai: 95.7%; Salavan: 86.4%; p<0.001) and drug 58 
resistance (Chiang Rai: 74.8%; Salavan: 62.5%; p<0.001), but the usage of technical concepts for 59 
antibiotics was dwarfed by local expressions like “anti-inflammatory medicine” in Chiang Rai (87.6%; 60 
95% confidence interval [CI]: 84.9–90.0) and “ampi” in Salavan (75.6%; 95% CI: 71.4–79.4). 61 
Multivariate linear regression suggested that attitudes against over-the-counter antibiotics were linked 62 
to 0.12 additional antibiotic use episodes from public healthcare providers in Chiang Rai (95% CI: 63 
0.01 – 0.23) and 0.53 in Salavan (95% CI: 0.16 – 0.90). 64 
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Conclusions: Locally specific conceptions and counter-intuitive practices around antimicrobials can 65 
complicate AMR communication efforts and entail unforeseen consequences. Overcoming 66 
“knowledge deficits” alone will therefore be insufficient for global AMR behaviour change. We call 67 
for an expansion of behavioural AMR strategies towards “AMR-sensitive interventions” that address 68 
context-specific upstream drivers of antimicrobial use (e.g. unemployment insurance) and complement 69 
education and awareness campaigns. 70 
Registration: clinicaltrials.gov identifier NCT03241316 71 
STRENGTH AND LIMITATIONS OF THIS STUDY 72 
• Provincial-level representative survey using three-stage stratified cluster random sampling 73 
design 74 
• Survey based on preceding qualitative research on antibiotic use in Southeast Asia 75 
• Inclusion of general population enables insights into formal and informal healthcare utilisation 76 
• Cross-sectional analysis of rural health behaviours excludes seasonal change and urban settings 77 
• Two-month recall period enabled greater inclusion but may bias responses towards better 78 
educated population groups  79 
MAIN TEXT 80 
Introduction 81 
Antimicrobial resistance (AMR) threatens modern medicine by rendering antimicrobial drugs 82 
ineffective. Multi-faceted global strategies target human, animal, and plant health alongside the 83 
environment and food production and safety to respond to this “superbug crisis” [1]. In human health, 84 
supply-sided responses include incentives to stimulate drug research and development; action on the 85 
demand side intends to limit and target antimicrobial use for instance through new diagnostic 86 
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technologies, public health intervention to improve vaccine coverage and hygiene, and other 87 
antimicrobial stewardship activities like restricted dispensing of antibiotics and prescriber feedback 88 
[2-4]. As an interdisciplinary field, the social dimensions of the problem are being recognised in global 89 
AMR policy, which are typically addressed via education and awareness-raising activities aimed at 90 
governmental staff, healthcare workers, and the general public [2]. 91 
Low- and middle-income countries (LMICs) play an important role in the global response to AMR. 92 
However, diverse health systems, healthcare practices, and conceptions related to the use of 93 
antimicrobials require social research to understand local contexts and the complexity of human 94 
behaviour in LMIC settings. For example, with a focus on the health behaviour of the general public, 95 
the anthropological literature suggests that social factors like precarity and discrimination can 96 
influence medicine use independently of awareness [5]; psychology and behavioural economics 97 
indicate that health decision-making processes interact with the social environment and contextual 98 
change to create adverse behavioural biases [6 7]; and communication studies research points at 99 
interferences between awareness campaigns and local contexts that can entail unforeseen 100 
consequences like politicisation, stigmatisation, or accidentally encouraging the behaviours they try to 101 
discourage [8 9]. Such examples underline the possible contribution of the social sciences to AMR, 102 
but they remain persistently underrepresented with less than 2% of all AMR-related publications (see 103 
Figure A1 in supplementary file 1for a time trend) [10]. This is problematic for at least three reasons: 104 
• We currently have an insufficient social science knowledge base for behavioural interventions 105 
in AMR—a global health priority that has attracted more than £600 million of AMR 106 
expenditure and future commitments [11-13]. 107 
• The recent withdrawal of large pharmaceutical companies from antimicrobial research and 108 
development [14] threatens the AMR supply-side response, requiring yet more effective action 109 
on the demand side. 110 
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• More extensive social sciences work can yield novel social innovations as a benefit of 111 
disciplinary diversification [15]. 112 
Using social research methods, the objectives of this paper were to (1) describe antibiotic-related 113 
knowledge, attitudes, and practices of the general population in two LMICs and to (2) assess the role 114 
of antibiotic-related knowledge and attitudes on antibiotic access from different types of healthcare 115 
providers. We report findings from a provincial-level representative survey of rural health behaviours 116 
across 69 villages in northern Thailand and 65 villages in southern Lao PDR as part of the 117 
interdisciplinary “Antibiotics and Activity Spaces” project [16].i We implemented the study in 118 
Southeast Asia, which is characterised as a region “at high risk of the emergence and spread of 119 
antibiotic resistance in humans” [17 18]. With more than 9% of global air passengers and more than 120 
110 million international tourist arrivals in 2016 [19], the potential of cross-border spread of drug-121 
resistant microbes also gives AMR research in Southeast Asia a global relevance—as the recent 122 
importation of multi-drug-resistant Neisseria gonorrhoeae to the UK showed [20]. Within Southeast 123 
Asia, Thailand and Lao PDR lent themselves for a comparative analysis because of their physical and 124 
cultural proximity, and Chiang Rai (Thailand) and Salavan (Lao PDR) in particular had similarly 125 
varied terrain and large and ethnically diverse rural populations. The main field site differences were 126 
Thailand’s more advanced economic and health system context and more established AMR action plan 127 
[21]. For example, Thailand maintains a national strategic plan on antimicrobial resistance (2017-128 
2021) [22]. In addition, according to World Bank data, Thailand’s public health expenditure per capita 129 
in 2016 were nearly ten times higher than Lao’s (USD 496.2 vs. USD 50.1 in purchasing power parity), 130 
and Thailand had 2.3 nurses per 1,000 people in 2015, compared to 1.0 per 1,000 people in Lao PDR 131 
in 2014 [19]. 132 
                                                 
i
 This paper contributes to the project’s research question, “What are the manifestations and determinants of problematic antibiotic use 
in patients’ healthcare-seeking pathways?” [16]. 
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Methods 133 
134 
Figure 1. Survey sites and multi-stage sampling process. 135 
Source: Authors, adapted from Wikimedia Commons [24]. 136 
Notes: Unavailable selections at each sampling stage were substituted with a random replacement for the random samples of PSUs and 137 
household members, and with the nearest available neighbour for the interval sample of households. One PSU could contain more than 138 
one administrative village; if the first-chosen village contained less than 600 houses, then adjacent villages would be included. 139 
PSU=Primary Sampling Unit. 140 
 141 
Multistage Survey Design 142 
Our study design was a three-stage stratified cluster random survey (ure 1): Following the purposive 143 
selection of five districts per province, we selected a random sample of 30 primary sampling units 144 
(PSUs) per province (six per district), stratified by distance to the nearest district headquarters. The 145 
second stage was the selection of an interval sample of 5% but at least 30 of all households in the PSU, 146 
which we approximated as residential structures on satellite maps [23]. Participants were sampled in 147 
the third and final stage. This process involved the random selection of available household members 148 
(one for every five members). At each sampling stage, we substituted unavailable selections (1) with 149 
a stratified random replacement for the random PSU sample, (2) with the nearest available neighbour 150 
for the interval sample of households, and (3) with a simple random replacement for the random 151 
a) Chiang Rai (Thailand) b) Salavan (Lao PDR)










Stage 1: Villages (stratified random sample)
30 PSUs (69 villages), 
15 replacements
30 PSUs (65 villages), 
59 replacements
Stage 0: District selection (purposive)
5 Districts 5 Districts
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household member sample (replacement numbers indicated in Figure 1). The cross-sectional data 152 
collection took place between November 2017 and May 2018. 153 
 154 
Study Population 155 
Our study population was the general adult population of rural Chiang Rai and Salavan (522,000 in 156 
Chiang Rai and 190,000 in Salavan as per census data), from whom we drew a representative sample 157 
of 1158 villagers in Chiang Rai and 983 in Salavan. We did not specifically sample patients, but we 158 
recorded any acute illness episode or accident-related injury if one occurred within the last two months 159 
of the interview, both for the respondents and any children under their supervision. 160 
 161 
Patient and Public Involvement 162 
This study did not sample patients but only adult members of the general public. The survey instrument 163 
was based on preceding qualitative research in Southeast Asia [25 26], in which patients, healthcare 164 
providers, and healthy adults participated, but patients or members of the public were not directly 165 
involved in the design or conception of the study. This preceding research prompted the research 166 
interest in treatment-seeking behaviours and conceptions of medicine and illness among the broader 167 
rural population in Southeast Asia. We will disseminate our findings through outreach to policy 168 
stakeholders and local development organisations, through public engagement activities like the World 169 
Antibiotic Awareness Week, and though our local network of collaborators in the field sites.  170 
 171 
Data Collection 172 
Our survey instrument was a 45-minute face-to-face questionnaire (see supplementary file 2). It was 173 
administered on tablets running the survey software SurveyCTO (Dobility Inc., Cambridge, MA, 174 
AUTHOR ACCEPTED MANUSCRIPT  Page 8 
USA) by locally recruited survey teams comprising seven enumerators and two survey supervisors per 175 
country, who received five days of full-time classroom and field training. The original English 176 
questionnaire was co-developed with, and translated into Thai and Lao by, the local research team,ii 177 
and local translators were recruited for the 228 instances where we encountered language barriers. The 178 
questionnaires were piloted in rural Chiang Rai and Salavan, with 50 cognitive interviews supporting 179 
the questionnaire development and revision as well as the contextualisation of the survey data (not 180 
reported here; interview guide in supplementary file 3) [27]. 181 
The questionnaire covered basic demographic and socio-economic information, antibiotic-related 182 
knowledge and attitudes, and treatment-seeking behaviour during acute illnesses and accident-related 183 
injuries. When measuring people’s awareness of antibiotics, we could not simply ask villagers whether 184 
they knew what “antibiotics” are, considering that (a) a variety of local terms related to antibiotics 185 
existed, (b) people may be familiar with specific antibiotic brands but not aware of their antibiotic 186 
attributes, and (c) the understanding of technical language was uncommon (see Results section for 187 
evidence on this point). We therefore asked respondents first if they recognised images of common 188 
antibiotics in the field site.iii In the 108/1974 (5.5%) of cases where the respondents did not mention 189 
“antibiotics,” its colloquial equivalents, or the names of specific antibiotic types, we asked them if they 190 
had heard about “anti-inflammatory drugs” (“ยาแกอ้กัเสบ” or “yah kae ak seb”) in Thai and “germ 191 
resisters” (“ຢາຕ້ານເຊ ື້ອ” or “yah dtan suea”) in Lao as common local notions of “antibiotics.” We next 192 
asked about the purposes for which the respondent would use these antibiotics, which served as 193 
                                                 
ii We refrained from additional back-translation as the local-language versions of the questionnaire were based on 
qualitative research material that we had previously used in the region, aided further by field pilots and cognitive 
interviewing. 
iii
 Three images on the survey tablet in Chiang Rai and a bag with seven local antibiotics in Salavan (considering the wider range of 
terms and medicines in circulation). See questionnaire in supplementary file 2. 
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information alongside inputs from local pharmacists to triangulate in later parts of the questionnaire 194 
whether the respondent received antibiotics during an illness. However, 752/2986 (25.2%) medicine 195 
use episodes could not be confirmed as either antibiotic or non-antibiotic (e.g. “white powder” or 196 
“green capsule”). We included these uncertain cases as “potential” antibiotic use episodes to capture 197 
behaviour more comprehensively. 198 
 199 
Data Analysis 200 
In order to inform the current global health agenda on antibiotic education and awareness raising, we 201 
used descriptive statistical analysis and regression analysis to describe the patterns of knowledge and 202 
attitudes – and their role in determining antibiotic use – across the two field sites, using the variables 203 
described in Table A1 in supplementary file 1. If the common policy narrative holds, then we would 204 
expect rural populations in Chiang Rai and Salavan to exhibit: 205 
• low degrees of antibiotic-related knowledge, 206 
• generally high levels of antibiotic consumption especially from informal sources (e.g. 207 
unregistered shops selling antibiotics over the counter), and 208 
• lower general antibiotic use and a higher share of supervised antibiotic use from formal 209 
healthcare providers among people whose attitudes correspond to awareness-raising messages 210 
for AMR (based on FAO/OIE/WHO material, see Table A1 in supplementary file 1) [1]. 211 
We stratified and compared the samples by field site (i.e. province) to account for the systemic 212 
influence of the health system configuration on people’s health knowledge and behaviour in Chiang 213 
Rai and Salavan. We estimated provincially representative patterns using post-stratification weights 214 
based on census data (considering village size and district-specific age and gender composition) and 215 
adjusting the descriptive and regression analysis results for the multi-stage sampling design with the 216 
help of the SVY suite of commands in Stata 15 (StataCorp, College Station, TX, USA). We separately 217 
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analysed the full sample and the subset of respondents who reported a recent illness, whereby we tested 218 
differences in knowledge, attitudes, and behaviours across provinces and across antibiotic access 219 
channels with Χ2 tests for binary and Wilcoxon rank-sum tests (two-sided) for non-normally distributed 220 
variables. We further carried out multivariate analysis of the determinants of antibiotic use from public 221 
(public hospitals and primary care units), private (private hospitals, clinics, and pharmacies), and 222 
informal sources (grocery stores selling medicine, traditional healers). The multivariate analysis used 223 
linear regression models adjusted by the complex survey design (sampling clusters and survey 224 
weights), which we compared across the two country samples, using the Chow test to ascertain 225 
systematic differences in the determinants of antibiotic use across the two field sites [28].iv We 226 
indicated significance levels below 0.1, 0.05, and 0.01 with *, **, and ***, respectively. 227 
                                                 
iv Although the dependent variables were not normally distributed, the otherwise preferable functional form of Poisson 
regression did not converge in most cases owing to the relatively small sample sizes. However, where they did converge, 
the linear regressions yielded more conservative estimates (likewise, the linear regressions adjusted by the complex survey 
design yielded more conservative results than linear multilevel models that take the hierarchical structure of the data into 
account). We therefore present the linear regression results in this article. For improved model fitness and to reduce the 
influence of outliers, we further substituted the duration of the illness with its log. To test for multicollinearity in the cross-
sectional survey data, we analysed the pairwise correlations between all independent variables stratified by field site, 
whereby the largest correlation coefficients in Chiang Rai were +0.59 (ethnicity/religion) and –0.50 (education/age), and 
in Salavan +0.76 (ethnicity/religion) and +0.62 (religion/wealth) (see Table A3 in supplementary file 1). The largest 
variance inflation factors (VIFs) were for the dummy variables of religion (VIF = 3.12 in the Salavan sample) and ethnicity 
(VIF = 2.01 in the Chiang Rai sample), the exclusion of which from the regression models did not produce meaningful 
differences in parameter estimates or significance levels of the other independent variables. We therefore presented the full 
regression models to not omit independent variables selectively. 
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Results 228 
Representative statistical data of Chiang Rai and Salavan are presented in Appendix Table 1. In terms 229 
of socio-demographic characteristics of the rural population in the two provinces, Chiang Rai villagers 230 
were older on average (p<0.001), tended to have received more formal education (p<0.001), and had 231 
higher asset wealth (p<0.001), while fewer Salavan villagers belonged to the local majority ethnicity 232 
(p=0.030). 233 
Respondents’ recognition of antibiotics in Chiang Rai was significantly higher than in Salavan, but 234 
overall high in both sites (Chiang Rai: 95.7%; Salavan: 86.4%; p<0.001). Recognition of the phrase 235 
“drug resistance” was high as well, whereby 74.8% recognised the term in Chiang Rai and 62.5% 236 
(p<0.001) recognised either of the two common variations in Salavan. Appendix Table 1 further 237 
indicates that antibiotic-related knowledge and attitudes aligned more closely with FAO/OIE/WHO 238 
messages in Chiang Rai than in Salavan (p<0.001 for all four questions). Across the four questions, 239 
respondents in rural Chiang Rai had an average answer score of 1.8 as opposed to rural Salavan with 240 
0.7 (p<0.001). 241 
Figure 2, Panel a, demonstrates the ways in which people related to “antibiotics.” In Chiang Rai, 242 
respondents commonly referred to antibiotics as “anti-inflammatory drug,” representing 87.6% of all 243 
responses (“ยาแกอ้กัเสบ” or “yah kae ak seb;” a vernacular notion specific to antibiotics).v Only 7.2% used 244 
the official term for “antibiotic” (“ยาปฏิชีวนะ” or “yah pa ti chee wa na”) alongside “germ killer” and 245 
specific antibiotic types like “corlam” (chloramphenicol; 4.6%). In rural Salavan, a larger portion of 246 
38.6% used the official term for antibiotics (“ຢາຕ້ານເຊ ື້ອ” or “yah dtan suea,” translated as “germ 247 
resister”), but Salavan respondents were also more likely to use various colloquial expressions for 248 
specific types of antibiotics, like “Ampi” with 75.6% and “Amok” with 35.3%. 249 
                                                 
v
 Actual anti-inflammatory medicine like ibuprofen would usually be referred to by its brand names. 
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 250 
 251 
Figure 2. Common names and purposes for antibiotics. 252 
Source: Authors’ analysis of survey data. 253 
Notes: Only including respondents who indicated that they had seen the presented medicine (i.e. common antibiotics) before. Chiang 254 
Rai: n = 1076; Salavan: n = 775. Population-weighted statistics, accounting for complex survey design. Multiple response permitted. 255 
Error bars indicate 95% confidence interval. 256 
 257 
Reported purposes of antibiotic use were yet more varied and are displayed in Figure 2, Panel b. The 258 
overall most common use was the treatment of external wounds (Chiang Rai: 33.7%; Salavan: 44.4%; 259 
p<0.001). Other frequently reported uses in Salavan included coughs (30.5%; Chiang Rai: 10.9%; 260 
p<0.001) and fevers (30.5%; Chiang Rai: 8.3%; p<0.001). Thai respondents further indicated common 261 
use of antibiotics for sore throats (Chiang Rai: 36.3%, where it was the single most common use; 262 
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Rai: 23.5%; Salavan: 18.6%; p=0.083). Thai respondents would also more often limit their use to 264 
whatever a healthcare worker would recommend (Chiang Rai: 9.5%; Salavan: 5.4%; p=0.037), while 265 
2.3% indicated that they would treat their plants or animals (dogs and chickens) with antibiotics 266 
(Salavan: 0.1%; p<0.001). Using antibiotics to treat infections or to fight bacteria and germs was only 267 
mentioned by a small minority of the rural populations (Chiang Rai: 2.4%; Salavan: 2.8%; p=0.243). 268 
Table 1 indicates that—though people typically recognised the term “drug resistance”—the responses 269 
to the question “What do you think is drug resistance?” only rarely corresponded to clinical definitions, 270 
and the coexistence of two common translations of the term in Lao PDR complicated the picture 271 
further. In Chiang Rai, 10.6% of the interpretations related to antibiotics and/or drug-resistant germs. 272 
Lao respondents linked the official term “due yah” to clinical definitions in 7.7% of all interpretations, 273 
and the colloquial term “lueng yah” in 9.6% of all interpretations. Not unlike other high- and low-274 
income countries [29], drug resistance was typically interpreted as a growing tolerance of the body 275 
towards medicine as a result of repeated use (not limited to antibiotics). Other common interpretations 276 
in Chiang Rai were the incorrect or erratic use of medicine (12.5%), and an understanding of drug 277 
resistance as side-effects of or allergic reactions to medicine in general (4.2%). In Salavan, “due yah” 278 
was often interpreted as a refusal or “stubbornness” to take medicine (21.8%; possibly due to its literal 279 
translation into “stubborn [to the effect of] medicine”), while its vernacular equivalent “lueng yah” 280 
was often interpreted in the opposite way as a psychological dependence or addiction to medicine 281 
(24.9%). 282 
According to our survey data, 99.9% of the rural population in Chiang Rai and 91.6% of the rural 283 
Salavan population had a public primary healthcare centre within a 10km radius. Private sources were 284 
more varied, as 93.0% and 34% of the rural Chiang Rai population had a private clinic and a pharmacy 285 
within a 10km radius, respectively (37.8% and 47.4% in Salavan, respectively), whereas informal 286 
healthcare through shops and informal healers was nearly universally available within the survey 287 
villages (>97.8% in all cases).  288 
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 289 
Table 1. Awareness and interpretations of “drug resistance.” 290 
 Chiang Rai Salavan 



















































































Source: Authors’ analysis of survey data. 291 
Notes: Ranking percentages only include respondents who indicated that they had heard the respective term “drug resistance” before. 292 
95% confidence intervals in parentheses. Chiang Rai: n = 871; Salavan (due yah): n = 206; Salavan (lueng yah): n = 470. Population-293 
weighted statistics, accounting for complex survey design. Only single response permitted. In Salavan, the common response “due yah 294 
means lueng yah” (24.8% [18.4–32.6]) was recoded to incorporate respondent’s definition of lueng yah. 295 
 296 
Among our 2141 respondents, we captured 608 illness episodes in Chiang Rai and 356 in Salavan 297 
(Appendix Table 1). Healthcare utilisation during these episodes varied slightly across the two field 298 
sites. Chiang Rai respondents accessed a narrower spectrum of healthcare providers and were 299 
significantly less likely to access public and “other” healthcare providers (p<0.001 in both cases). Both 300 
sites also exhibited a high level of medicine access, with 2.2 and 2.5 medicine use episodes during an 301 
illness Chiang Rai and Salavan, respectively (p=0.050). Respondents in Chiang Rai thereby indicated 302 
higher use of non-antibiotic medicine (Chiang Rai: 1.6; Salavan: 1.3; p=0.048). In contrast, 303 
respondents in Salavan had more episodes of antibiotic use per illness (Chiang Rai: 0.2; Salavan: 0.4; 304 
p<0.001), and more usage of medicines that could potentially include antibiotics (Chiang Rai: 0.4; 305 
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Salavan: 0.9; p<0.001). The pattern of antibiotic access was similar for informal sources, but generally 306 
lower in Chiang Rai: confirmed antibiotic use from informal channels represented 1.6% of all medicine 307 
use episodes in Chiang Rai and 3.3% in Salavan; and 3.6% in Chiang Rai and 7.9% in Salavan if 308 
unconfirmed but potential antibiotic use episodes are included. 309 
Comparing the bivariate differences between individuals who accessed antibiotics from public, private, 310 
and informal sources (see Table A2 in supplementary file 1) indicated that, contrary to intuition, 311 
patients receiving antibiotics from informal sources had no less wealth or formal education than users 312 
of public healthcare. Indeed, wealthier and more educated individuals in Chiang Rai were significantly 313 
associated with receiving antibiotics from informal sources (wealth: p=0.012; education: p=0.032). 314 
Similarly, awareness of drug resistance was not significantly lower among patients who received 315 
antibiotics from informal sources, while the share of respondents who linked drug resistance to 316 
biomedical notions of AMR in Salavan was significantly higher among individuals accessing 317 
antibiotics through informal channels compared to public channels (13.4% vs. 4.4%, p=0.030). 318 
Patients who accessed antibiotics through informal channels were nevertheless significantly more 319 
inclined towards buying over-the-counter antibiotics than public antibiotic users (Chiang Rai: p=0.040; 320 
Salavan: p<0.001). 321 
The results of the multivariate analysis are presented in Table 2. The dependent variables were the 322 
number of confirmed antibiotic use episodes from public, private, and informal sources; as a sensitivity 323 
check, we also included the more inclusive definition of “confirmed and potential” antibiotic use 324 
episodes. The relationship between antibiotic-related knowledge and attitudes and antibiotic use was 325 
mixed. Among the most common knowledge- and attitude-related predictors of antibiotic use was the 326 
respondents’ inclination to buy antibiotics. Again contrary to expectations, the attitude to not buy 327 
antibiotics over the counter was linked to disproportionate consumption of antibiotics from public 328 
sources. For example, patients who would not buy antibiotics over the counter would have 0.12 329 
additional potential antibiotic use episodes in Chiang Rai (Model 7; 95% CI: 0.01 – 0.23) and up to 330 
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0.53 in Salavan (Model 8; 95% CI: 0.16 – 0.90), ceteris paribus. Also knowledge of antibiotics was 331 
positively associated with antibiotic consumption from private sources in Chiang Rai (Model 3) and 332 
from public and informal sources in Salavan (Models 2 and 6). In contrast, other antibiotic-related 333 
attitudes and knowledge linked negatively to antibiotic consumption. For example, the knowledge that 334 
antibiotic resistance can spread was linked to 0.25 fewer potential antibiotic use episodes from 335 
informal sources (Model 12, 95% CI: -0.39 – -0.10) and Chiang Rai patients who preferred alternatives 336 
over antibiotics had 0.12 fewer confirmed antibiotic use episodes from private sources (Model 3; 95% 337 
CI: -0.22 – -0.03). 338 
Among other covariates, wealthier patients had lower consumption of antibiotics from public (Chiang 339 
Rai and Salavan, Models 7 and 8) but also higher consumption from private (Salavan, Model 4) and 340 
informal healthcare providers (Chiang Rai, Models 5 and 11) – presumably enabled by their higher 341 
purchasing power. Speakers of the majority language were also more likely to consume more 342 
antibiotics from public sources, which resonates with anecdotes encountered during the field research 343 
according to which speakers of minority languages tended to be less assertive in the patient-doctor 344 
encounter (the link to education was less clear). Not surprisingly, longer illness episodes were also 345 
associated with more antibiotic use episodes from public and private sources. 346 
The Chow test indicated that the determinants of confirmed antibiotic use from private sources were 347 
significantly different in Chiang Rai and Salavan (Models 3 and 4; p=0.011), as were all sources of 348 
potential and confirmed antibiotic use (Models 7 to 12; p=0.056, p=0.015, and p=0.083 for public, 349 
private, and informal antibiotic use, respectively). 350 
  351 
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Table 2. Regression results of determinants of antibiotic use from public, private, and informal sources. 352 
 Confirmed antibiotic use episodes Confirmed and potential antibiotic use episodes 





Public providers Private providers 
Informal 
providers 
Site CR SAL CR SAL CR SAL CR SAL CR SAL CR SAL 
Model number (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) 
Independent variables             
Would not buy antibiotics 
over the counter 
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Model Statistics             
Number 604 356 604 356 604 356 604 356 604 356 604 356 
R2 0.102 0.106 0.080 0.133 0.104 0.046 0.143 0.218 0.126 0.136 0.052 0.095 
F statistic 2.29*** 3.34*** 1.89** 1.79** 0.89 1.48 2.82*** 4.57*** 2.41*** 1.30 1.18 2.27*** 
Chow Test (2) – (1) = 0 (4) – (3) = 0 (6) – (5) = 0 (8) – (7) = 0 (10) – (9) = 0 (12) – (11) = 0 
F statistic 1.33 2.05** 1.08 1.65* 1.97** 1.55* 
Source: Authors’ analysis of survey data. 353 
Notes: Illness episode level, including completed illnesses experienced by respondent or child under their supervision, excluding 354 
incomplete episodes. Population-weighted statistics, accounting for complex survey design. 95% confidence intervals in parentheses. 355 
CR = Chiang Rai. SAL = Salavan. 356 
*p < 0.1, **p < 0.05, ***p < 0.01. 357 
a. Comparing Thai “due yah” with the combined Lao “due yah” and “lueng yah.” 358 
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Discussion and Conclusion 359 
Our paper aimed at understanding AMR-related general population behaviour in LMICs through a 360 
description of antibiotic-related knowledge, attitudes, and practices in rural Thailand and Lao PDR, 361 
and an assessment of the role of antibiotic-related knowledge and attitudes on antibiotic access from 362 
different types of healthcare providers. We demonstrated that rural populations exhibited: 363 
• mixed but surprisingly high levels of awareness and attitudes corresponding to AMR 364 
awareness-raising material, although only a minority of villagers were familiar with technical 365 
notions of antibiotics and drug resistance; 366 
• relatively low levels of antibiotic access from informal sources; and 367 
• surprisingly counter-intuitive links between informal antibiotic use, socio-economic status, and 368 
their attitudes—especially among villagers in Salavan, who had disproportionately high 369 
antibiotic use if their attitude showed a disinclination against over-the-counter antibiotics. 370 
Our survey data also revealed profound differences between the two field sites despite their cultural 371 
and geographical proximity. For example, villagers referred to antibiotics with wide-ranging and 372 
locally specific vernacular expressions (only a minority adopted technical language in either site), and 373 
“drug resistance” was typically understood as a general tolerance of the body to medicine but local 374 
interpretations ranged from patients refusing medicine to patients being addicted to medicine. Some 375 
of these differences could be explained by the local health system configuration. The better endowed 376 
and more regulated health system as well as the more extensive public health campaigns in Chiang Rai 377 
arguably contributed to the higher rates of public awareness and the comparatively lower rates of 378 
antibiotic use, whereas the Salavan health system faced more pressing trade-offs between ensuring 379 
access to and preventing the overuse of antibiotics. Alas, as the analysis has shown, antibiotic-related 380 
awareness and attitudes appeared to have little bearing on people’s antibiotic consumption when 381 
controlling for other determinants of medicine use. 382 
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The surveys were implemented after the Monsoon season to reduce accessibility barriers like 383 
landslides, floods, and farm work. This temporal focus meant that our survey was not able to capture 384 
internal migration or seasonal change affecting the epidemiological environment. The rural survey is 385 
also unable to speak for urban health behaviour or behavioural patterns outside rural Thailand and Lao 386 
PDR, or for awareness and behaviour among healthcare staff and policy makers (with which 387 
awareness-raising activities for the general public may interact). Lastly, our focus on health behaviour 388 
and our 60-day recall period could introduce recall and social desirability biases. Most LMIC health 389 
behaviour research uses 14-30-day recall periods; longer recall periods can lead to underrepresentation 390 
of lower educated groups [30]. However, for a survey of behaviour rather than of epidemiological 391 
patterns, 14-day recall would have truncated the sample to an impractical size (omitting 540/964 392 
[56.0%] of all responses) and neglected that illness episodes often extended beyond a fortnight (as was 393 
the case for 91/964 [8.7%] of the recorded illnesses). In response, we conducted regular review 394 
sessions with our survey team to identify and alleviate social desirability; we excluded chronic 395 
illnesses; and our questionnaire asked our respondents to walk through the sequence of events, which 396 
improves recall [31]. While we cannot rule out a residual risk of social desirability and recall bias, it 397 
is not clear a priori whether and how any remaining bias would affect our comparison of antibiotic 398 
uses across different healthcare providers. 399 
By virtue of being a representative rural survey in northern Thailand and southern Lao PDR, the 400 
specific notions and behavioural patterns around antibiotic use are not generalisable beyond the study 401 
context, although similar interpretations of antibiotics as “anti-inflammatory medicine” exist 402 
elsewhere (e.g. in China) [32], and even the documented practice of using antibiotics in plant 403 
cultivation has historical antecedents [33]. Other study findings like the widespread use of antibiotics 404 
for external (and often allegedly “internal”) wounds have few documented equivalents in other settings 405 
and deserve further research. However, the findings of our study have a broader relevance insofar as 406 
they expose the complexity of local knowledge and its relationship to AMR-related behaviour. On the 407 
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one hand, our work underlines the challenges facing public awareness campaigns as the current 408 
principal strategy to change AMR-related population behaviour. For example, if not mindful of the 409 
local context, the slogan of the 2017 World Antibiotic Awareness Week to “use antibiotics wisely to 410 
combat rising drug resistance” could plausibly entail increased antibiotic use or the use of stronger 411 
medicine if people understand drug resistance as stubbornness of patients or as a problem applying to 412 
all types of medicines. 413 
On the other hand, our study also demonstrated that the link between knowledge, attitudes, and 414 
antibiotic-related behaviour may be weak in LMIC contexts. This disjunction is not new [5], but the 415 
counter-intuitive link between awareness, antibiotic-related attitudes, and antibiotic use from informal 416 
sources suggests that AMR-related information can easily entail unintended consequences—417 
knowledge and awareness empower, but people themselves decide how they will use this new “power” 418 
in their daily lives [34]. For instance, villagers may not necessarily buy antibiotics from private clinics 419 
and unregulated corner shops because of ignorance, but because they become more assertive about 420 
their health (and increased wealth may enable patients to exercise this assertiveness). 421 
Considering potential misunderstandings in AMR communication on the one hand and contextual 422 
determinants of behaviour beyond knowledge deficits on the other, we call for an expansion of 423 
behavioural AMR strategies to address structural factors of behavioural change. For example, 424 
vulnerability and adversity may drive people into seemingly irrational antimicrobial use [35]. A sick 425 
labourer or factory worker may take antimicrobials desperately to maintain their job and to sustain 426 
their families, in which case it would be futile trying to convince them that their hardship is secondary 427 
to the global health goal of tackling AMR. Yet, it may be possible to alleviate their pressure to consume 428 
antimicrobials through paid sick leave and unemployment insurance. We propose the exploration of 429 
such “AMR-sensitive interventions” to address upstream drivers of antimicrobial use and to 430 
complement education and awareness campaigns—similar to nutrition-sensitive interventions that 431 
target the determinants of mal- and undernutrition through upstream interventions like social safety 432 
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nets (rather than e.g. providing supplements directly to people) [36]. AMR-sensitive interventions 433 
require us to venture out of health policy terrain into broader development policy. There is yet little 434 
evidence whether and how such context-oriented approaches bear fruit. Greater involvement of the 435 
social sciences is necessary to uncover this gap and to find constructive solutions that address the social 436 
factors of which AMR is a symptom. 437 
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Appendix Figure A1. Trend of AMR-related social sciences and multidisciplinary publications, 1970–1 
2017. 2 
 3 
Source: Authors, based on Elsevier B.V. [15]. 4 
Notes: Data until 2018, as of 9 October 2018. Disciplines as reported by Scopus database, with “‘Social Sciences’ + related disciplines” 5 
providing upper bound of social science publications including Arts and Humanities;” “Business, Management and Accounting;” 6 
“Decision Sciences;” “Economics, Econometrics and Finance;” and “Psychology” alongside “Social Sciences.” Based on search query 7 
[TITLE-ABS-KEY (“antibiotic resistance” OR “drug resistance” OR “antimicrobial resistance” OR “AMR”)]. Total number of 8 
publications as of 9 October 2018 was 347,511, of which 66.0% arose from “Medicine;” 28.3% from “Biochemistry, Genetics and 9 
Molecular Biology;” and 18.2% from “Immunology and Microbiology” (multiple categories per publication possible.) “Social Sciences” 10 
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Female Binary variable: Sex of respondent (R); [1] if female. 
Age Continuous variable: Age in years. 
Education Continuous variable: Completed years of formal education. 
Speaking Thai / Lao Binary variable: [1] if R reported ability to communicate in main language (irrespective of reading and writing). 
Wealth index Continuous variable: Average of 17 household assets and amenities on scale from [0] to [1]. 
Buddhist religion Binary variable: [1] if R belongs to the majority religion (Buddhism in both sites). 
Thai/Lao nationality Binary variable: [1] if R has Thai (Chiang Rai) or Lao (Salavan) nationality. 
























Aware of antibiotics 
Binary variable: [1] if R recognised images of antibiotic capsules that are common in the field site and, if not, 
the most common translation of antibiotics as “anti-inflammatory drug” (“ยาแกอ้กัเสบ” or “yah kae ak seb”) in Thai 
and “germ resister” (“ຢາຕ້ານເຊ ້ ອ” or “yah dtan suea”) in Lao. Additional categorical variables (coded ex ante 
and ex post) recorded the names and purposes that the respondent reported following recognition of the 
medicine. 
Aware of drug resistance 
Binary variable: [1] if R recognised the local terms for “drug resistance.” In Thai, “drug resistance” was 
translated as “ด้ือยา” (“due yah”). Lao has two translations of which “ດ ້ ຍາ” (“due yah”) is the formal term and “ລ ້ ງ
ຍາ” (“lueng yah”) is a more colloquial but broader expression (both translations were asked separately). 
Additional categorical variables (coded ex ante and ex post) recorded the interpretations of each term. 
Would not buy antibiotics over 
the counter 
Binary variable: [1] if answer to question “Is there any situation for which you would buy this medicine?” 
corresponded to FAO/OIE/WHO message “When using antibiotics: follow professional advice” (field coded 
based on survey training manual) [1]. 
Prefers alternatives over 
antibiotics 
Binary variable: [1] if answer to question “Do you prefer other remedies such as herbs or cough syrup to this 
medicine for sore throat?” corresponded to FAO/OIE/WHO message “Ensure medicines are only used when 
necessary” (field coded) [1].  
Does not keep antibiotics for 
future use 
Binary variable: [1] if answer to question “If you were prescribed this medicine by a doctor and did not finish 
the course, would you keep it for future use?” corresponded to FAO/OIE/WHO message “When using 
antibiotics: never share medicines or use leftover drugs to treat a different illness” (field coded) [1].  
Knows that antibiotic resistance 
can spread 
Binary variable: [1] if answer to question “Can your ‘due yah’ (drug resistance) spread to other people, for 
example if you sneeze on them?” corresponded to FAO/OIE/WHO message “antimicrobial resistance can affect 
us all” (field coded) [1].  












s Self-rated severity Ordinal variable: [1] if illness is reported as “mild;” [2] as “moderate;” [3] as “severe.” 
Duration of illness episode 























Public healthcare provider Binary variable: [1] if R reported accessing health centre or hospital during illness episode. 
Private healthcare provider Binary variable: [1] if R reported accessing private clinic, hospital, or pharmacy. 
Informal healthcare provider Binary variable: [1] if R reported accessing grocery store or traditional healer. 
Care from family or self-care Binary variable: [1] if R reported self-treatment or care from family member or friend. 
Other types of healthcare access Binary variable: [1] if R reported accessing other healthcare provider (e.g. village health volunteer). 
Medicines use episodes 
Continuous variable: Number of reported medicine use episodes per illness, categorised into types of medicine 
(coded ex post into non-antibiotic medicine, antibiotics, and potential antibiotics) and sources of access (public, 
private, informal healthcare provider). Note that the actual amount of medicine used during each “medicine use 
episode” is likely to vary systematically across formal and informal healthcare providers, with “episodes” from 
the latter typically containing only a small number of pills and capsules for immediate treatment of symptoms. 
Source: Authors.  13 
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Appendix Table A3. Characteristics of individuals who received antibiotics from public, private, and 14 
informal sources. 15 




































Number 93 115 35 200 110 132 157 38 41 179 178 77 
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Does not keep 
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Knows that antibiotic 














0.986 0.172 0.341 














0.064 0.061 0.964 
Source: Authors’ analysis of survey data. 16 
Notes: Including antibiotics and unconfirmed medicines that may include antibiotics. Illness-level data, including only completed 17 
illnesses experienced by respondent or a child under their supervision. Population-weighted statistics, accounting for complex survey 18 
design. Multiple types of healthcare access per individual and illness episode possible. 19 
a. Comparing Thai “due yah” with the combined Lao “due yah” and “lueng yah.” 20 
b. Corresponding to interpretation of “drug resistance” as “Reference to antibiotics, drug-resistant germs” in Exhibit 6. 21 
c. Χ2 and Wilcoxon rank-sum tests, omitting simultaneous antibiotic access from more than one type of healthcare provider, which was 22 
the case in 82/958 [8.6%] of all pairwise comparisons of antibiotic access. 23 
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1. Village Checklist (GPS coordinates of village and facilities) (to be completed by supervisor)  
 
What kind of facility would you like to record?  
A. District Number [code entered automatically] 
B. Village Number  [code entered automatically] 
C. Village centre  
a) Latitude [coordinates entered automatically] 
b) Longitude [coordinates entered automatically] 
D. Village head’s house  
a) Latitude  [coordinates entered automatically] 
b) Longitude [coordinates entered automatically] 
E. Local shop  
a) Latitude  [coordinates entered automatically] 
b) Longitude  [coordinates entered automatically] 
F. Market  
a) Latitude  [coordinates entered automatically] 
b) Longitude  [coordinates entered automatically] 
G. Temple  
a) Latitude  [coordinates entered automatically] 
b) Longitude  [coordinates entered automatically] 
H. School  
a) Latitude  [coordinates entered automatically] 
b) Longitude  [coordinates entered automatically] 
I. Bus stop  
a) Latitude  [coordinates entered automatically] 
b) Longitude  [coordinates entered automatically] 
J. Health facility  
Specify (public, private, 
pharmacy, local store, 
traditional healer, etc.):  
_________________ 
a) Latitude  [coordinates entered automatically] 
b) Longitude  [coordinates entered automatically] 
c) Who is staffing the facility? Total staff: ___ 
Staff at time of visit: ________ 
d) Does the provider have antibiotics available? Yes .................................. 1 
No ................................... 0 
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Interview data [Record observation]  
i. District Number  [code entered automatically] 
ii. PSU Number  [code entered automatically] 
iii. Household number  Number: ______ 
iv. Household 
coordinates  
a) Latitude [coordinates entered automatically] 
b) Longitude  [coordinates entered automatically] 






vi. Time of visit  
a) First visit  [time entered automatically] 
b) Second visit  [time entered automatically] 
List all persons aged 18+ years in household 
Hello, I’m a researcher working for the Mahidol-Oxford Tropical Medicine Research Unit. We are interested in the lives and health behaviours 
of villagers across Thailand and Lao PDR. We are selecting participants randomly and would like to choose one or two members of your 
household. In order to choose and ask them to participate, could you please tell us who lives here? [provide PIS on request] 
[1 respondent per every 5 household members will be selected randomly from this list] 
Name  Nickname  Sex (M / F)  Age  Available for interview today? (Yes / No)  
     
     
     
Statement of consent (Respondent will receive participant information sheet and verbal consent will be taken)  
Thank you for participating. You will receive a small token of gratitude for your participation at the end of the interview.  
vii.Date of interview [date entered automatically] 
viii.Time of interview begin [time entered automatically] 
ix.Respondent name  Respondent name: ____________________________ 
x.Interviewer code  [code entered automatically] 
Part I: Personal and Household Characteristics  
Let us begin with a few questions about yourself and your household. 
1. [record as observed] Sex Female ........................ 1 
Male ........................... 0 
2. How old are you? [in years] [If respondent cannot give exact age, ask for approximate age and 
code in range: 18-24, 25-34, 35-44, 45-59, 60 and older] 
Age in years: _______ 
3. Please indicate what kind of work you do. If you have more than one occupation at 
one time or throughout the year, please begin with the one in which you spend the most 
time and name up to three. If you do not have an occupation, please also mention 
whether you are still a student, retired, or unemployed. 
a) Main occupation Occupation: _________ 
b) Side occupation Occupation: _________ 
c) Side occupation Occupation: _________ 
4. What is your mother tongue? Mother tongue: ________________ 
5. [In Thailand:] Can you speak Thai? [In Laos:] Can you speak Lao? Yes ..................................................... 1 
No ...................................................... 0 
6. What is the highest grade of schooling that you completed? 
[excluding informal education and pre-school education such as nursery and kindergarten, but including grade school, high 
school, vocational training, tertiary education, etc.] Highest grade: ___ 
7. Are you the head of your household? Yes .........................1  
No ..........................0 
7.1. [if no] What is the name of your household head? Name: __________ 
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8. What is your current marital status? Never married ...................................................................................................................... 1 
Currently married ................................................................................................................ 2 
Cohabiting ............................................................................................................................ 3 
Separated / divorced ........................................................................................................... 4 
Widowed .............................................................................................................................. 5 
9. Are there any close family members 
of yours [children, spouse, siblings, 
parents] who live elsewhere? 
[select “no” if not applicable] 
9.1. Do your parents live outside of this village? [do not 
count parents-in-law] 
At least 1 person outside village .... 1 
All inside village / not applicable .... 0 
9.2. Does your spouse live outside of this village? At least 1 person outside village .... 1 
All inside village / not applicable .... 0 
9.3. Do you have siblings who live outside of this 
village? [do not count brothers-in-law and sisters-in-law] 
At least 1 person outside village .... 1 
All inside village / not applicable .... 0 
9.4. Do you have children who live outside of this 
village? 
At least 1 person outside village .... 1 
All inside village / not applicable .... 0 
Part II: Social Networks [for network census villages only] 
I will now ask you some questions about your interactions with other people within and outside of your village. 
10. [Round I of network survey only] Where do you 
spend most of your time interacting with 
other people from your village? 
  
a) Field: ___ 
b) Temple: ___ 
c) Local store: ___ 
d) Market: ___ 
e) Children’s schools: ___ 
f) Home: ____ 
g) Workplace: ___ 
h) Village event/s: ______  
i) Other site: ___ 
  
 
OxTREC reference: 528-17  ANTIBIOTICS AND ACTIVITY SPACES 
14 November 2017. Version No: 4.0                                        Page 4 of 12 
 
11. [Round I of network survey only] Outside your household, with whom do you interact on a regular basis? (May be anyone from both inside and outside of the village, and through any platform which might not 
require a face-to-face interaction) 
 a) What is the nickname of the person? 
 
 
b) How is this person related to you? 
 
[give examples if respondent is unsure 
about answer categories] 
c) What is 
the sex of 
this person? 
d) Where does 
this person live? 
e) What is the 
name of the 
household 
head of this 
person? 
f) How often do you interact with 
this person? 
g) How do you 
interact with 
this person?  
 
[Mark all that 
apply] 
h) Do your 
conversations 




Nickname _____  
Name _____ 
Spouse ................................................. 1 
Parent.................................................. 2 
Child .................................................... 3 
Sibling .................................................. 4 
Other relative ..................................... 5 
Neighbour ........................................... 6 
Friend (if not neighbour) .................... 7 
Other villager ...................................... 8 
Other (specify) _ ................................. 9 
Female... 1 
Male ...... 0 
 
In village  ........... 1 
(specify: _____) 
 






Daily or more often ...................4 
Weekly or few times/week .......3 
Monthly or few times/month ...2 
Yearly or few times/year ...........1 
Less often or never ....................0 
Face-to-face ... 1 
Voice call ........ 2 
Messenger ..... 3 
Other (specify)  
_____ ............... 4 
 
Yes ...................... 1 







1  2  3  4  5  6  7  8  9 1  0 1  2 Name 0  1  2  3  4 1  2  3  4 1  0 
11a. [Round II of network survey only] When we last visited you, you told us that you interact regularly with 
[names]. Has anything changed since last time? 
Yes ......................... 1   [update social network question 11] 
No .......................... 0 
11i. [Round I of network survey only] Is there anybody in your household with whom you talk about health 
and well-being? [Mark all that apply] 
[mark all names from household roster that apply] 
 
OxTREC reference: 528-17  ANTIBIOTICS AND ACTIVITY SPACES 
14 November 2017. Version No: 4.0                                        Page 5 of 12 
[For network survey village respondents in Round 2] 
12. An education activity has recently taken place in your village.  
12.1. Did you participate in any of the activities? Yes .................................................................................................................................. 1 
Yes, but not throughout ................................................................................................ 2 
No ................................................................................................................................... 3 
Don't know / prefer not to say ..................................................................................... 4 
12.2. Did you talk with anybody about the activity in your 
village?  
[“Talking” can involve any conversation including asking for 
information, informing about the educational activity, or 
discussing it (regardless of actual attendance)]  
 
a) Nickname 1: ______    b) Full name 1: ______     c) Relationship 1: 1 2 3 4 5 6 7 
a) Nickname n: ______    b) Full name n: ______     c) Relationship n: 1 2 3 4 5 6 7 
 
[Relationship codes] 
Household member ............................................................................................................................ 1 
Family member outside HH ................................................................................................................ 2 
Other relative ...................................................................................................................................... 3 
Neighbour ............................................................................................................................................ 4 
Friend other than neighbour .............................................................................................................. 5 
Other villager ....................................................................................................................................... 6 
Other (specify) _ ................................................................................................................................. 7 
[If respondent indicates conversation in Q 12.2] 
12.3. What subjects did you talk about in respect to the 
activity?  
 [mark all that apply] 
Going to doctor when sick ................................................................................................ 1 
Anti-inflammatories/antibiotics ....................................................................................... 2 
Germs ................................................................................................................................. 3 
Using medicines correctly ................................................................................................. 4 
Activity in general .............................................................................................................. 5 
Games/awards ................................................................................................................... 6 
Song/Story/Play ................................................................................................................. 7 
Money/compensation ....................................................................................................... 8 
Other (specify) ____ .......................................................................................................... 9 
Part III: Healthcare Seeking Thank you for this. Now we come to a part where I will ask you some questions about health and health providers 
around here. 
13. I would now like to ask you 
about the sources of health 
advice and medicine or other 
treatment that are available to 
you. Please think about all the 
places where you can go to get 
advice, treatment, or drugs if you 
(or your children) are sick.  
 
Do you consider the following 
providers when you (or your 
children) feel unwell?  
 
[Mark all that apply] 
13.1. Drug dispensary, 
other local store selling 
medicine 
Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
13.2. Traditional healer  Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
13.3. Pharmacist  Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
13.4. Private clinic  Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
13.5. Private hospital Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
13.6. Health volunteer Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
13.7. Public primary 
care unit  
Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
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13.8. Public hospital Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
13.9. Other providers 
or Internet? Specify: 
_________ 
Consultation ............................................................................................................... 1 
Medical advice............................................................................................................ 2 
Access to medicine..................................................................................................... 3 
Other reason(s) .......................................................................................................... 4 
Don’t consider this provider ...................................................................................... 98 
Don’t know such a provider ...................................................................................... 99 
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14. Now if you think again, is there anyone else with whom you talk about health? 
 a) What is the 




b) What is the full 
name of the person? 
 
 
c) How is this person related to you? 
 
[give examples if respondent is unsure 
about answer categories] 
d) What is 
the sex of 
this person? 
e) Where does 
this person live? 
f) What is the 
name of the 
household 
head of this 
person? 
g) How often do you interact with 
this person? 
h) How do you interact with this 
person?  
 
[Mark all thatapply] 
14.1.  
Contact 1  
Name ______ Name ______ 
Spouse................................................. 1 
Parent ................................................. 2 
Child .................................................... 3 
Sibling .................................................. 4 
Other relative ..................................... 5 
Neighbour ........................................... 6 
Friend (if not neighbour).................... 7 
Other villager ...................................... 8 
Other (specify) _ ................................. 9 
Female .. 1 
Male ...... 0 
 
In village  ........... 1 
(specify: _____) 
 






Daily or more often ...................4 
Weekly or few times/week .......3 
Monthly or few times/month ...2 
Yearly or few times/year ...........1 
Less often or never ....................0 
Face-to-face ............................ 1 
Voice call ................................. 2 
Messenger .............................. 3 




Name Name 1  2  3  4  5  6  7  8  9 1  0 1  2 Name 0  1  2  3  4 1  2  3  4 
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15. Did you or a child in your household have an acute illness (not a chronic, long-term condition that comes 
again and again) or an accident in the last two months? If yes, I will ask you about these illnesses one-by-one. 
[if no, continue with Question 19] 
No........................ 0  [Q 16] 
Yes ....................... 1  
[if yes:] 
 15.a [Confirm if this episode is for respondent or child] 
Respondent .......................................................... 1   [Q 15.1] 
Child ...................................................................... 2 
 15.b How old is the child?  Age in years: _______ 
 15.c Is the child female or male  Female ...................................... 1  
Male .......................................... 0  
15.1. Can you please describe the symptoms or problem in your own 
words?  
Description of condition:  
__________________________________________ 
15.2. Did [you / the child] receive a diagnosis of the illness from 
any medical provide, friend, or internet source?  
 
If so, can you please describe the diagnosis of the illness if you 
received any and where [you / the child] received it? [note: the 
diagnosis might be given by any medical provider including 
untrained and informal. Record all diagnoses if more than one.] 
a) Diagnosis 1: ___________    b) Medical provider 1: 1 2 3 4 5 6 7 8 
a) Diagnosis n: ___________    b) Medical provider n: 1 2 3 4 5 6 7 8 
 
[Response codes] 
Drug dispensary, other local store selling medicine  ..........................................................1 
Traditional healer..................................................................................................................2 
Pharmacist ............................................................................................................................3 
Private clinic ..........................................................................................................................4 
Private hospital .....................................................................................................................5 
Primary care unit ..................................................................................................................6 
Public hospital .......................................................................................................................7 
Other providers or Internet? Specify: ________................................................................ 8 
15.3. When did [you / the child] experience the accident/discomfort (for the first time) Onset: ___ days / ______ weeks / _____ months ago 
15.4. Would you describe the illness/accident as “mild,” “moderate,” or “severe”?  Mild .....................................................1  
Moderate ............................................2  
Severe .................................................3  
15.5. Can you please explain the stages of the treatment? I will ask you step-by-step what you did, starting from the moment [you / the child] 
first experienced a discomfort. 
 15.5.1. Step 1 (detection)  Step n  
a) What kind of help 
or treatment did 
you get at this 
stage?  
[if unsure, specify]  
Ignored /did nothing .................................................................................................................................................1 
Self-care (sleep, rest, medicine at home) ................................................................................................................2 
Care from family and friends (full-time) ...................................................................................................................3 
Treated/consulted at a traditional healer ................................................................................................................4 
Treated/cons. at a pharmacist ..................................................................................................................................5 
Treated/cons. at shop selling drugs ..........................................................................................................................6 
Treated/cons. at priv. clinic/hospital ........................................................................................................................7 
Treated/cons. at primary care unit ...........................................................................................................................8 
Treated/cons. at a gvt. Hospital ................................................................................................................................9 











b) Where did this activity take place?  At home ..................................................................................................................... 1 
Less than 10 min. from home................................................................................... 2 
10 to 29 min. ............................................................................................................. 3 
30 to 59 min. ............................................................................................................. 4 
60 to 119 min. ........................................................................................................... 5 







c) How did [you / the child] get to the place of the 
activity? [select “at home” according to prior 
responses]  
At home ..................................................................................................................... 1 
Walk ........................................................................................................................... 2 
Own bicycle ............................................................................................................... 3 
Own motorcycle / Three-wheeler ............................................................................ 4 
Own car / four-wheeler ............................................................................................ 5 
Taxi or other hired ride ............................................................................................. 6 
Public transport ......................................................................................................... 7 









d) How long did this stage last?  
[let respondent choose category; if <1 day, code “1” 
day] 
Duration:  
___ days  
___ weeks  
___ months  
___ days  
___ weeks 
__ months  
e) Can you please name or describe all the medicines that you received or 
were prescribed during this step? 
 
[include medicine stored at home if “self-care at home”] [continue for all 
medicines received, then complete Questions g to k for each medicine 
individually] 
Medicine 1:  
Name/description: _____ 
 








f) For how long did [you / the child] take the medicine?  
[let respondent choose category; if more than one repeated episode, indicate total 
duration]  
[for each medicine individually] 
Duration:  
___ days  
___ weeks  
___ months 
___ days  
___ weeks 
__ months  
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g) How often per day did [you / the child] take the medicine?  
 
[calculate into daily use according to respondent’s chosen frequency]  
[for each medicine individually] 
Frequency: ___ times daily  
___ times 
daily 
h) What dosage did [you / the child] normally take? 
[let respondent choose category according to type of 
medicine]  
[for each medicine individually] 
Dosage 
___ tablets / capsules 
___ drops (for liquid medicine) 
___ spoons (for liquid medicine) 
____ shots/injections (for intravenous medicine) 
per time administered 
___ tablets 
___ drops 
___ spoons  
___ shots 
i) Did [you / the child] take the medicine exactly as it was recommended 
to you by the person who prescribed/sold them 
[for each medicine individually] 
Yes ....................................................................................... 1 
No ........................................................................................ 0 
Did not receive advice ........................................................ 9 





j) Did [you / the child] finish the medicine?  
[for each medicine individually] 
Yes ............................ 1 
No ............................. 0 
1 
0 
k) Did you or anybody else use a mobile phone during this stage in connection with your 
condition? [if no, go to next step] 
Yes ............................ 1 
No ............................. 0  [next step] 
1 
0 
l) What was the purpose of using the 
mobile phone?  
 
[Mark all that apply]  
 
 
Ask for advice ............................................................................................................................. 1 
Call for treatment ...................................................................................................................... 2 
Arrange transport ...................................................................................................................... 3 
Appointment .............................................................................................................................. 4 
Reassure family/friends ............................................................................................................. 5 
Ask for money/supplies ............................................................................................................. 6 
Provider contacting me for information ................................................................................... 7 
Treatment reminder .................................................................................................................. 8 










m) Which mobile phone functions did 
you or anybody else use?  
[Mark all that apply]  
Call .............................................................................................................................................. 1 
SMS ............................................................................................................................................. 2 
Internet, messenger .................................................................................................................. 3 
Alarm, calendar, reminder, etc. ................................................................................................ 4 






15.6. [Have you / has the child] now recovered 
from the illness/accident?  
Yes ............................ 1 
No ............................. 0 
15.7. Was anybody of your personal 
relationships involved in providing advice or help 
during the illness? [record up to ten names] 
Yes ............................ 1 
No ............................. 0 
[For district survey] 
 15.7.b How are these people related to 
you? [Mark all that apply] 
Spouse ....................................... 1 
Parent........................................ 2 
Child .......................................... 3 
Sibling ........................................ 4 
Other relative ........................... 5 
Neighbour ................................. 6 
Friend (if not neighbour) .......... 7 
Other villager ............................ 8 
Other (specify) _ ....................... 9 
 15.7.c What kind of support did they 
provide? [Mark all that apply] 
Providing healthcare/attending.............................................................................................. 11 
Providing advice ...................................................................................................................... 12 
Providing medicine .................................................................................................................. 13 
Lending/granting money ......................................................................................................... 21 
Transportation/Lending vehicle ............................................................................................. 22 
Contacting family/friends ....................................................................................................... 23 
Providing food ......................................................................................................................... 31 
Helping with children/housework .......................................................................................... 32 
Helping with jobs/agriculture work (feeding animals/tending crops/covering shifts, etc.) 33 




a) What is the 
name of the 
person?  
b) How is this person 
related to you?  
c) What kind of support was provided?  
[mark all that apply] 
15.7.1.  
Contact 1  
Name: 
_______ 
Spouse ....................... 1 
Parent........................ 2 
Child .......................... 3 
Sibling ........................ 4 
Other relative ........... 5 
Neighbour ................. 6 
Friend (if not  
neighbour) ................ 7 
Other villager ............ 8 
Other (specify) _ ....... 9 
Providing healthcare/attending.............................................................................................. 11 
Providing advice ...................................................................................................................... 12 
Providing medicine .................................................................................................................. 13 
Lending/granting money ......................................................................................................... 21 
Transportation/Lending vehicle ............................................................................................. 22 
Contacting family/friends ....................................................................................................... 23 
Providing food ......................................................................................................................... 31 
Helping with children/housework .......................................................................................... 32 
Helping with jobs/agriculture work (feeding animals/tending crops/covering shifts, etc.) 33 
Other (specify) _ ...................................................................................................................... 99 
15.7.2.  
Contact n  
Name  1  2  3  4  5  6  7  8  9 11  12  13  21  22  23  31  32  33  99 
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15.8. Did you have another acute illness (not a chronic, long-term condition that comes again 
and again) or an accident in the last two months?  
[if yes, complete another sheet for Question 15] 
Yes ............................ 1  [Q 15]  
No ............................. 0  
16. I would now like to ask you your opinion about medicine. There are no right or wrong 
answers, I only want to understand what you think. Consider the following medicines: 
 
16.1. Have you seen these medicines before?  Yes ..................... 1  
No ..................... 0  [Q 16.4] 
16.2. What do you call this medicine? Antibiotics ทา่นเรยีกยานี้วา่อะไร....................................................................................................... 11 
Anti-inflammatory ยาแกอ้กัเสบ .................................................................................................... 12 
Germ killer ยาฆา่เชือ้ ................................................................................................................... 13 
Amoxy / Amoxicillin อะมอ็กซี/่อะมอ็กซีซ่ลิลนิ ................................................................................... 14 
Sore throat medicine ยาแกเ้จบ็คอ ............................................................................................... 15 
Cough medicine ยาแกไ้อ ............................................................................................................ 16 
Pain reliever ยาแกป้วด ................................................................................................................ 17 
Fever reliever ยาแกไ้ข ้................................................................................................................ 18 
Other (specify: ____) อื่นๆ (โปรดระบุ) .......................................................................................... 98 
Germ preventer / antibiotic ຢາຕ້ານເຊ ້ ອ .............................................................................. 21 
Amok ຢາຕ້ານເຊ ້ ອ .................................................................................................................. 22 
Ampi ຍາແອມປ ້  ...................................................................................................................... 23 
Tetra ຍາເຕຕ້າ ........................................................................................................................ 24 
Gulolam ກູໂລລາມ ................................................................................................................... 25 
Sepasin ເຊພາຊິ ນ .................................................................................................................... 26 
Other (specify: __) ................................................................................................................... 99 
16.3. What symptoms or illnesses would you use 
this medicine for?  
Fever ........................................................................................................................................ 1 
Cough ....................................................................................................................................... 2 
Sore throat ............................................................................................................................... 3 
Inflammation ........................................................................................................................... 4 
Cold, flu, runny nose ............................................................................................................... 5 
Diarrhoea ................................................................................................................................. 6 
Headache ................................................................................................................................. 7 
Stomach ache .......................................................................................................................... 8 
Muscle pain, other aches ........................................................................................................ 9 
Skin diseases, rashes, lumps ................................................................................................... 10 
Wounds .................................................................................................................................... 11 
Urinary tract infections ........................................................................................................... 12 
Every kind of sickness.............................................................................................................. 13 
Whatever the doctor suggests ............................................................................................... 14 
Don’t know / prefer not to say ............................................................................................... 98 
Other (specify: __) ................................................................................................................... 99 
16.4. Is there any situation for which you would 
buy this medicine?  
Desirable attitude/knowledge ................................................................................................ 1 
Undesirable attitude/knowledge ........................................................................................... 0 
No attitude / refuse to answer (respondent is aware, but doesn’t reveal attitude) ........... 97 
Answer does not apply to question (respondent may be aware/unaware; satisficing)...... 98 
Not aware of this medicine (awkward, cannot answer but does not try to satisfy) ........... 99 
16.5. Do you prefer other remedies such as herbs 
or cough syrup to this medicine for [sore throat]?  
Desirable attitude/knowledge ................................................................................................ 1 
Undesirable attitude/knowledge ........................................................................................... 0 
No attitude / refuse to answer (respondent is aware, but doesn’t reveal attitude) ........... 97 
Answer does not apply to question (respondent may be aware/unaware; satisficing)...... 98 
Not aware of this medicine (awkward, cannot answer but does not try to satisfy) ........... 99 
16.6. If you were prescribed this medicine by a 
doctor and did not finish the course, would you 
keep it for future use?  
Desirable attitude/knowledge ................................................................................................ 1 
Undesirable attitude/knowledge ........................................................................................... 0 
No attitude / refuse to answer (respondent is aware, but doesn’t reveal attitude) ........... 97 
Answer does not apply to question (respondent may be aware/unaware; satisficing)...... 98 
Not aware of this medicine (awkward, cannot answer but does not try to satisfy) ........... 99 
16.7. Have you heard about drug resistance? 
(16.7a using alternative term “lueng yah” in Lao) 
Yes ................................ 1 
No ................................. 2 
16.8. What do you think is 
drug resistance?  
(16.8a using alternative term 
“lueng yah” in Lao) 
Bacteria are resistant to medicine ..................................................................................................................... 1 
Antibiotics become less effective if used wrongly/too much ........................................................................... 2 
Medicine in general becomes less effective if used wrongly/too much .......................................................... 3 
Being stubborn to take medicine ....................................................................................................................... 4 
Being addicted to medicine ................................................................................................................................ 5 
Drug allergy ......................................................................................................................................................... 6 
Lueng yah (drug resistance) ............................................................................................................................... 7 
Answer does not relate to drug resistance ........................................................................................................ 8 
Other (specify) ..................................................................................................................................................... 98 
“Don’t know” ....................................................................................................................................................... 99 
16.9. Can your drug resistance ("due yah") spread 
to other people, for example if you sneeze on 
them? 
Desirable attitude/knowledge ................................................................................................ 1 
Undesirable attitude/knowledge ........................................................................................... 0 
No attitude / refuse to answer (respondent is aware, but doesn’t reveal attitude) ........... 97 
Answer does not apply to question (respondent may be aware/unaware; satisficing)...... 98 
Not aware of this medicine (awkward, cannot answer but does not try to satisfy) ........... 99 
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Part IV: Household assets  
We now come to the last part. Can you please provide me with some information about your household?  
17. How many rooms does this house have apart from toilet and hallways? Number of rooms: ________ 
18. What is the electricity situation in your household 
on a typical day?  
 
Power at all times, no power cuts (90-100%) ............................................................. 1 
Power most of the time, occasional power cuts (>50%) ............................................ 2 
Power sometimes, frequent power cuts (<50%) ........................................................ 3 
No electricity ................................................................................................................. 4 
19. What kind of toilet does this house have and is it 
shared with other people in this community?  
[if more than one, choose “best” toilet] [use show card to 
facilitate answers] 
Unshared flush toilet (e.g. piped sewer system, septic tank, pour flush toilet) ........ 1 
Shared (flush or non-flush) toilet with other community members or public toilet  2 
No facility, Bush, Field, or others ................................................................................. 3 
20. What is the drinking water source of this house and 
is it shared with other people in this community?  
[use show card to facilitate answers]  
Water piped into house or yard ................................................................................... 1 
Water not directly piped into house or yard (e.g. well, borehole, water from 
spring, rainwater, tanker truck, surface water including rivers, bottled water, etc.)2  
21. What kind of fuel does this household use for 
cooking?  
Improved fuel source (e.g. Electricity, gas stove, etc.) ............................................... 1 
Unimproved fuel source (e.g. Coal / Lignite, Charcoal, Wood, Straw / Shrubs / 
Grass, Animal dung, Agricultural crop residue) .......................................................... 2 











tell me…  
Number of items in household:  
22.1. Have you got a functioning radio in your household? If so, how many?  __ 
22.2. Have you got a functioning TV in your household? If so, how many? __ 
22.3. Have you got a functioning rice cooker in your household? If so, how many? __ 
22.4. Have you got a functioning landline telephone in your household? If so, how many? __ 
22.5. Have you got a functioning mobile phone in your household? If so, how many?  __ 
22.6. Have you got a functioning computer in your household? If so, how many?  __ 
22.7. Have you got a functioning bicycle in your household? If so, how many?  __ 
22.8. Have you got a functioning scooter, motorcycle, or tricycle in your household? If so, how many?  __ 
22.9. Have you got a functioning car or truck in your household? If so, how many?  __ 
22.10. Have you got a functioning tractor in your household? If so, how many?  __ 
22.11. Have you got a functioning refrigerator or freezer in your household? If so, how many?  __ 
23. How long does 
it normally take you 
to get to the 
following places?  
23.1. How long does it take to get to the nearest 
market?  
Less than 10 minutes ......................................................... 1 
10 to 29 minutes ................................................................ 2 
30 to 59 minutes ................................................................ 3 
60 to 119 minutes .............................................................. 4 
2 hours or more .................................................................. 5 
23.2. How long does it take to get to the village hall 
or the village head's house?  
Less than 10 minutes ......................................................... 1 
10 to 29 minutes ................................................................ 2 
30 to 59 minutes ................................................................ 3 
60 to 119 minutes .............................................................. 4 
2 hours or more .................................................................. 5 
23.3. How long does it take to get to the nearest 
public or private doctor? 
Less than 10 minutes ......................................................... 1 
10 to 29 minutes ................................................................ 2 
30 to 59 minutes ................................................................ 3 
60 to 119 minutes .............................................................. 4 
2 hours or more .................................................................. 5 
24. What is your religion?  No religion ........................................................................... 0 
Buddhist ............................................................................... 1 
Christian ............................................................................... 2 
Muslim ................................................................................. 3 
Spirit (religious belief in Lao) .............................................. 4 
Other (Specify) __________ ............................................... 5 
Don’t know ........................................................................99 
25. What is your nationality?  Thai ...................................................................................... 1 
Lao........................................................................................ 2 
Myanmar/Burmese ............................................................. 3 
Chinese ................................................................................ 4 
Other (Specify) __________ ............................................... 9 
Don’t know ........................................................................99 
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26. What is your ethnic background?  Thai ...................................................................................... 1 
Tai Yai ................................................................................... 2 
Akha (E-Koh) ........................................................................ 3 
Pakakeryor (Karen) .............................................................. 4 
Lahu (Muser) ....................................................................... 5 
Lisu (Lisaw) .......................................................................... 6 
Hmong (Meaw) ................................................................... 7 
Mien (Yao) ........................................................................... 8 
Burmese ............................................................................... 9 
Yunnan (Jin Haw) ...............................................................10 




Bahnaric Khmer .................................................................23 
Tai Thai...............................................................................24 
 
Other (Specify) ________ .................................................30 
Don’t know ........................................................................99 
xi. Interview end time  [time entered automatically] 
Thank you very much for participating in this survey. [give gift to respondent] 
Part V: Interviewer observations [to be completed by interviewer after interview]  
xii. Was the interview completed?  
 
Yes ....................................................................................................... 1 
Yes, with difficulties ........................................................................... 2 
No ....................................................................................................... 3 
xiii. Was someone else present during the interview?   
[mark all that apply] 
Survey supervisor .................................................................................. 1 
Other household or family member .................................................... 2 
Medical practitioner .............................................................................. 3 
Government officer ............................................................................... 4 
Other (specify) ____.............................................................................. 5 
No one ................................................................................................... 0 
xiv. What is your evaluation of the accuracy and trustworthiness of 
the informant's answers?  
Very good .......................................................... 1 
Satisfactory ........................................................ 2 
Doubtful ............................................................. 3 
Very low ............................................................. 4 
xv. Were there any unusual circumstances during the interview? Please describe: ____________________________________ 
 
OxTREC reference: 528-17 ANTIBIOTICS AND ACTIVITY SPACES 
20 June 2017. Version No: 2.0                                        Page 1 of 17 
INTERVIEW GUIDES – COGNITIVE INTERVIEWS FOR SURVEY TESTING 
บทสัมภาษณ์ – การสัมภาษณ์กระบวนการคดิเพ่ือการทดสอบแบบสอบถาม 
ບົດສໍາພາດ - ການສໍາພາດຂະບວນການຄດິເພ ື່ອການທົດສອບຄາໍຖາມ 
 
Objective วัตถุประสงค์ ຈຸດປະສົງ 
To understand how survey participants understand the survey questions and arrive at their answers. เพื่อเรียนรู้วา่ผูเ้ขา้ร่วม
งานวิจยัมีการท าความเขา้ใจค าถามท่ีใชใ้นแบบสอบถามอยา่งไร และมีความคิดอยา่งไรก่อนตดัสินใจตอบค าถามแต่ละขอ้ ເພ ື່ອຮຽນຮ ູ້ວ່າຜ ູ້ເຂົົ້າຮ່ວມການຄົົ້ນຄູ້ວາມີຄວາມ
ເຂົົ້າໃຈຄໍາຖາມທີື່ໃຊູ້ໃນແບບສອບຖາມແບບໃດ ແລະມີຄວາມຄິດແບບໃດກ່ອນຕັດສິນໃຈຕ ໍ່ຄໍາຖາມແຕ່ລະຂ ໍ້
 
Introduction บทน ำ ບົດນໍາ 
<Obtaining verbal informed consent in accordance with Oral Consent Script> <ด าเนินการขอค ายินยอมโดยใชข้อ้ความส าหรับอธิบาย
งานวิจยัและขอค ายินยอมเขา้ร่วมการวิจยัดว้ยวาจา> <ດໍາເນີນການຂ ຄໍາຍິນຍອມໂດຍໃຊູ້ຂ ໍ້ຄວາມສໍາລັບອະທິບາຍວຽກຄົົ້ນຄູ້ວາແລະຂ ຄໍາຍິນຍອມເຂົົ້າຮ່ວມການ
ຄົົ້ນຄູ້ວາດູ້ວຍວາຈາ> 
 
Thank you for agreeing to participate in this study. ขอบคุณท่านส าหรับการตกลงเข้าร่วมการวิจัยคร้ังนี ้ຂອບໃຈທ່ານສໍາລັບການຕົກລົງເຂົົ້າຮ່ວມ
ການຄົົ້ນຄູ້ວາໃນຄັົ້ງນີົ້ 
 
Part I – About Yourself ส่วนท่ี 1 – เก่ียวกับตัวท่ำน ສວ່ນທີື່ 1 - ກຽ່ວກບັຕວົທາ່ນ 
Let us start with a few questions about yourself. เราจะเร่ิมโดยถามค าถามเก่ียวกบัขอ้มูลส่วนตวัของท่าน ເຮົາຈະເລີື່ມໂດຍຖາມຄໍາຖາມກ່ຽວກັບຂ ໍ້
ມ ນສ່ວນຕົວຂອງທ່ານ 
Guiding question: Who is my informant? ค าถามน า: ผูใ้หส้มัภาษณ์คือใคร ຄໍາຖາມນໍາ: ຜ ູ້ໃຫູ້ສໍາພາດແມ່ນໃຜ 
 
1. How old are you? อายขุองท่าน ອາຍຸທ່ານ 
2. What is your level of education? การศึกษาสูงสุดของท่าน ການສຶກສາສ ງສຸດຂອງທ່ານ 
3. What is your ethnicity and nationality? เช้ือชาติ และ สญัชาติของท่าน ເຊ ົ້ອຊາດແລະສັນຊາດຂອງທ່ານ 
Part II – Practicing the “Think Aloud” Technique ส่วนที ่2 – เทคนิคการคดิออกเสียง (การบรรยายกระบวนการคดิ) ສວ່ນທີື່ 2 - ເທກັນກິ
ການຄດິອອກສຽງ (ການບນັລະຍາຍຂະບວນການຄດິ) 
Thank you. As we are trying to improve our survey, you can help us develop the questionnaire by participating in 
this interview. I would like to ask you to describe your thoughts as you think about the question and the answer as 
though you are talking to yourself. For example, what do you think as you receive the question? What does the 
question make you think of? In what way do you want answer to question? How do you arrive at your answer? Let 
me give you an example so you understand this type of interview better. 
Let’s say I was asked a question about “What do you see when you go from your home to the nearest temple?” If I 
was thinking out loud, I would say “[interviewer describing their own village].” So you can see how it works, though 
that was only one of many ways. The important thing is that there are no right or wrong answers. What really matters 
is your view and thought process. And this is what I would like you to share with me. So now it is your turn to practice. 
ขอบคุณครับ/ค่ะ เน่ืองจากเราก าลงัอยู่ในช่วงปรับปรุงแบบสอบถาม ท่านสามารถช่วยเราพัฒนาแบบสอบถามนีไ้ด้โดยการเข้าร่วมการสัมภาษณ์นี ้ ซ่ึงเราจะขอให้ท่านบรรยาย
ความคิดของท่านในขณะท่ีท่านพิจารณาค าถามและค าตอบเสมือนกับท่านก าลงัคุยกับตนเอง เช่น ท่านคิดอย่างไรเม่ือท่านได้รับค าถาม ค าถามท าให้ท่านนึกถึงอะไรบ้าง ท่าน
ต้องการตอบค าถามเหล่านีอ้ย่างไร ท่านได้ค าตอบมาได้อย่างไร เราจะยกตวัอย่างให้ท่านหน่ึงตัวอย่างเพ่ือให้ท่านสามารถเข้าใจการสัมภาษณ์ในลกัษณะนีม้ากขึน้ 
ยกตัวอย่าง ถ้าเราต้องตอบค าถามท่ีว่า “ท่านมองเห็นอะไรบ้างหากท่านเดินทางจากบ้านไปวัดท่ีใกล้ท่ีสุด” และเราต้องบรรยายความคิดของเราให้ท่านฟัง เราจะพูดว่า “[ผู้สัมภาษณ์
บรรยายการเดินทางในหมู่บ้านของตนเอง]” ซ่ึงเป็นเพียงแค่หน่ึงในหลากหลายวิธีท่ีท่านสามารถใช้ได้ ส่ิงท่ีส าคัญท่ีสุดเก่ียวกับการคิดออกเสียงของท่านคือค าตอบของท่านจะไม่
ถกูตัดสินว่าถกูหรือผิด เพราะส่ิงท่ีเราต้องการเรียนรู้มากท่ีสุดคือมุมมองและวิธีการคิดของท่าน และนั่นคือส่ิงท่ีเราอยากให้ท่านแบ่งปันกับเรา ดังนั้นเราจึงขอให้ท่านลองคิดออก
เสียงกับเราในค าถามต่อไปนี ้
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ຂອບໃຈ ເນ ື່ອງຈາກເຮົາກໍາລັງຢ ູ່ໃນຊ່ວງປັບປຸງແບບສອບຖາມ ທ່ານສາມາດຊ່ວຍເຮົາພັດທະນາແບບສອບຖາມນີົ້ໄດູ້ໂດຍການເຂົົ້າຮ່ວມການສໍາພາດນີົ້ ເຊິື່ງ
ເຮົາຈະຂ ໃຫູ້ທ່ານບັນລະຍາຍຄວາມຄິດຂອງທ່ານໃນຕອນທີື່ທ່ານກໍາລັງພິຈາລະນາຄໍາຖາມແລະຄໍາຕອບຄ ກັບທ່ານກໍາລັງລົມກັບຕົນເອງ ເຊັັ່ນ ທ່ານຄິດ
ແນວໃດເມ ື່ອທ່ານໄດູ້ຮັບຄໍາຖາມ ຄໍາຖາມເຮັດໃຫູ້ເຮົາຄິດຫາຫຍັງແດ່ ທ່ານຕູ້ອງການຕອບຄໍາຖາມເຫ ົັ່ານີົ້ແນວໃດ ທ່ານໄດູ້ຄໍາຕອບມາໄດູ້ແນວໃດ ເຮົາຈະຍົກ
ຕົວຢູ່າງໃຫູ້ທ່ານໜຶື່ງຕົວຢູ່າງເພ ື່ອໃຫູ້ທ່ານສາມາດເຂົົ້າໃຈການສໍາພາດໃນລັກຊະນະນີົ້ຫ າຍຂ ົ້ນ. 
ຍົກຕົວຢູ່າງ ຖູ້າເຮົາຕູ້ອງຕອບຄໍາຖາມວ່າ ທ່ານເບິື່ງເຫັນຫຍັງແດ່ຖູ້າທ່ານເດີນທາງຈາກເຮ ອນຫາວັດທີື່ໃກູ້ທີື່ສຸດ ແລະເຮົາຕູ້ອງບັນລະຍາຍຄວາມຄິດຂອງເຮົາ
ໃຫູ້ທ່ານຟັງເຮົາຈະເວົົ້າວ່າ “[ຜ ູ້ສໍາພາດບັນຍາຍການເດີນທາງໃນໝ ່ບູ້ານຂອງຕົນເອງ]” ເຊິື່ງເປັນພຽງໜຶື່ງໃນຫ າກຫ າຍວິທີທີື່ທ່ານສາມາດໃຊູ້ໄດູ້ ສິື່ງທີື່ສໍາຄັນທີື່
ສຸດກ່ຽວກັບການຄິດອອກສຽງຂອງທ່ານຄ ຄໍາຕອບຂອງທ່ານຈະບ ໍ່ຖ ກຕັດສິນວ່າຖ ກຫ  ຜິດ ເພາະສິື່ງທີື່ເຮົາຕູ້ອງການຮຽນຮ ູ້ຫ າຍທີື່ສຸດມຸມມອງແລະວິທີການ
ຄິດຂອງທ່ານ ແລະນັົ້ນແມ່ນສິື່ງທີື່ເຮົາຢາກໃຫູ້ທ່ານແບ່ງປັນກັບເຮົາ ດັັ່ງນັົ້ນເຮົາຈຶື່ງຂ ໃຫູ້ທ່ານລອງຄິດອອກສຽງກັບເຮົາໃນຄໍາຖາມຕ ໍ່ໄປນີົ້ 
Guiding question: Is the respondent comfortable with the “think aloud” technique? ค าถามน า: ผูใ้หส้มัภาษณ์สามารถใชเ้ทคนิคการคิด
ออกเสียงหรือไม่ ຄໍາຖາມນໍາ: ຜ ູ້ໃຫູ້ສໍາພາດໃຊູ້ເຕັກນິກການຄິດອອກສຽງຫ  ບ ໍ່ື່
4. I would like you to imagine your village. Could you please describe to me what you see when you go from your 
home to the nearest temple, in as much detail as you can? เราขอใหท่้านนึกภาพหมู่บา้นของท่านและบรรยายใหเ้ราฟังวา่ท่านเห็นอะไรเม่ือ
ท่านเดินทางจากบา้นของท่านไปยงัวดัท่ีใกลท่ี้สุด โดยใชร้ายละเอียดมากท่ีสุดเท่าท่ีท่านสามารถท าได ้ເຮົາຂ ໃຫູ້ທ່ານນຶກພາບໝ ່ບູ້ານຂອງທ່ານແລະບັນຍາຍໃຫູ້ເຮົາ
ຟັງວ່າທ່ານເຫັນຫຍັງເມ ື່ອທ່ານເດີນທາງຈາກເຮ ອນຂອງທ່ານໄປຫາວັດທີື່ໃກູ້ທີື່ສຸດ ໂດຍໃຊູ້ລາຍລະອຽດຫ າຍທີື່ສຸດທີື່ທ່ານສາມາດເຮັດໄດູ້ 
 
Before we start, I’d like to give you another example that is more closely related to the actual questions from our 
questionnaire. Say you ask me to list all persons age ≥18 years in my household with their sex and age, I’d go 
[interviewer answering question about adults in household]. ก่อนท่ีเราจะเร่ิม เราขอยกตัวอย่างท่ีใกล้เคียงกับค าถามจริงกับแบบสอบถามของเรา
ให้ท่านอีกหน่ึงคร้ัง สมมติท่านขอให้เราบอกข้อมูลของสมาชิกอายุ 18 ปีหรือมากกว่า ท่ีอาศัยอยู่ในครัวเรือนนีทุ้กคน รวมถึงเพศและอายุ เราจะพดูว่า “[ผู้สัมภาษณ์ให้ค าตอบ
เก่ียวกับสมาชิกในครัวเรือนของตนเอง].” ກ່ອນທີື່ເຮົາຈະເລີື່ມເຮົາຂ ຍົກຕົວຢູ່າງທີື່ຄູ້າຍກັນກັບແບບສອບຖາມຂອງເຮົາ ສົມມຸດທ່ານບອກໃຫູ້ເຮົາບອກຂ ໍ້ມ ນຂອງ
ຊະມະຊິກອາຍຸ 18 ປີຫ  ຫ າຍກ່ວາ ທີື່ອາໄສຢ ູ່ໃນຄົວເຮ ອນນີົ້ທຸກຄົນ ລວມເຖິງເພດແລະອາຍຸ ເຮົາຈະເວົົ້າວ່າ “[ຜ ູ້ສໍາພາດໃຫູ້ຄໍາຕອບກ່ຽວກັບສະມາຊິກໃນຄົວ
ເຮ ອນຂອງຕົນເອງ]” 
 
List all persons aged 18+ years in household กรอกข้อมูลของสมาชิกอายุ 18 ปีหรือมากกว่า ที่อาศัยอยู่ในครัวเรือนนี้ ໃສຂ່ ໍ້ມ ນຂອງຊະມະຊກິອາຍຸ 18 ປຫີ  ຫ າຍກວ່າ ທີື່ອາໃສ
ຢ ູ່ຄົວເຮ ອນນີົ້ 
[1 respondent per every 5 household members will be selected randomly from this list] [ตัวแทน 1 คนต่อสมาชิกจ านวน 5 คน จะถูกสุ่มเลือกให้เข้าร่วมการ
สัมภาษณ์] [ຕົວແທນ 1 ຄົນຕ ໍ່ຊະມະຊິກຈໍານວນ 5 ຄົນ ຈະຖ ກສຸ່ມເລ ອກໃຫູ້ເຂົົ້າຮ່ວມການສໍາພາດ] 
Name ช่ือ ຊ ື່
Sex เพศ ເພດ 
 
(M / F) (ช/ญ) (ຊ/ຍ) 
Age อาย ุອາຍຸ 
(in completed Years) (จ านวนปีเตม็) 
(ຈໍານວນປີເຕັມ) 
Available for interview today ผูเ้ขา้ร่วมสามารถให้สมัภาษณ์ในวนัน้ี
หรือไม่ ຜ ູ້ເຂົົ້າຮ່ວມສາມາດໃຫູ້ສໍາພາດໃນມ ົ້ນີົ້ໄດູ້ຫ  ບ ໍ່? 
(Yes / No) (ใช่/ไม่ใช่) (ແມ່ນ/ບ ໍ່ແມ່ນ) 
    
    
    
 
Part III – Social-Network-Related Survey Questions ส่วนท่ี 3 – ค ำถำมเก่ียวกับเครือข่ำยสังคม ສວ່ນທີື່ 3 - ຄາໍຖາມກຽ່ວກບັເຄ ອຂາ່ຍ
ສງັຄມົ 
I will now ask you some questions about your interactions with other people within and outside of your village. เราจะ
เร่ิมโดยการถามค าถามท่านเก่ียวกับปฏิสัมพันธ์ของท่านกับชาวบ้านคนอ่ืนๆ ท้ังในและนอกหมู่บ้าน ເຮົາຈະເລີມໂດຍການຖາມຄໍາຖາມທ່ານກ່ຽວກັບການພົວພັນຂອງ
ທ່ານກັບຊາວບູ້ານຄົນອ ື່ນໆ ທັງໃນແລະພາຍນອກຂອງໝ ່ບູ້ານ 
 
5. What are you thinking about when you hear the following question? ท่านมีความคิดอะไรบา้งเม่ือท่านไดย้ินค าถามต่อไปน้ี ທ່ານມີ
ຄວາມຄິດຫຍັງແດ່ເມ ື່ອທ່ານໄດູ້ຍິນຄໍາຖາມຕ ໍ່ໄປນີົ້ 
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Where do you spend most of your time 






[mark all that apply or select 99 if respondent 
indicates no noteworthy interaction] [ตอบได้
มากกว่า 1 ตัวเลือก หรือเลือก 99 หากไม่มีปฏสัิมพนัธ์ที่เด่นชัดปรากฏ] 
[ຕອບໄດູ້ຫ າຍກວາ່ 1 ຕວົເລ ອກ ຫ  ເລ ອກ 99 ຖູ້າບ ໍ່ມີການ
ພວົພນັທີື່ຊດັເຈນ]  
Field (specify) ไร่นา (โปรดระบุ) ໄຮ່ນາ (ກະລຸນາບອກ) ___ ................................................. 1 
Temple (specify) วดั (โปรดระบุ) ວັດ (ກະລຸນາບອກ) ___ .................................................. 2 
Local store (specify) ร้านคา้ (โปรดระบุ) ຮູ້ານຄູ້າ (ກະລຸນາບອກ) ___ .................................... 3 
Market (specify) ตลาด (โปรดระบุ) ຕະຫ າດ (ກະລຸນາບອກ) ___ ............................................ 4 
Children’s schools (specify) โรงเรียนของบุตรหลาน (โปรดระบ)ุ ໂຮງຮຽນຂອງລ ກ (ກະລຸນາບອກ) __
 ............................................................................................................................ 5 
Home (specify) ท่ีบา้น (โปรดระบุ) ເຮ ອນ (ກະລຸນາບອກ) ____ ............................................ 6 
Workplace (specify) ท่ีท างาน (โปรดระบุ) ບ່ອນເຮັດວຽກ (ກະລຸນາບອກ) ___ ........................... 7 
Other site (specify) อ่ืนๆ (โปรดระบุ) ອ ື່ນໆ (ກະລຸນາບອກ) ___ ........................................... 8 
 
I don’t interact notably with others ไม่มีปฏิสมัพนัธ์ท่ีเด่นชดักบัชาวบา้นคนอ่ืนๆ  
ບ ໍ່ມີການພົວພັນທີື່ຊັດເຈນກັບຊາວບູ້ານຄົນອ ື່ນໆ................................................................. 99 
 
a. How do you understand “interacting?” ส าหรับท่าน ท่านคิดวา่ค าวา่ “พบปะพูดคุย” มีความหมายวา่อยา่งไร ສໍາລັບທ່ານ ທ່ານຄິດວ່າ 
“ການພົບປະໂອູ້ລົມ” ມີຄວາໝາຍວ່າແນວໃດ 
b. What does “most of your time” mean to you? Which time frame did you have in mind? ค าวา่ “เวลาส่วนมาก” 
ส าหรับท่านมีความหมายวา่อยา่งไร ในขณะท่ีท่านตอบค าถามในใจของท่านนึกถึงช่วงเวลาใด ຄໍາວ່າ “ເວລາຫ າຍທີື່ສຸດ” ສໍາລັບທ່ານມີຄວາມໝາຍວ່າ
ແບບໃດ ໃນຂະນະທີື່ທ່ານຕອບຄໍາຖາມໃນໃຈຂອງທ່ານນຶກເຖິງຊ່ວງເວລາໃດ 
c. What are the possible places where people spend time together? มีท่ีใดบา้งท่ีชาวบา้นสามารถใชเ้วลาร่วมกนัได ้ມີບ່ອນໃດແດ່
ທີື່ຊາວບູ້ານສາມາດໃຊູ້ເວລາຮ່ວມກັນໄດູ້ 
d. Please ask us the same question in your own words. กรุณาถามค าถามน้ีกบัเราโดยใชค้  าพูดในแบบของท่านเอง ກະລຸນາຖາມຄໍາຖາມ
ນີົ້ກັບເຮົາໂດຍໃຊູ້ຄໍາເວົົ້າໃນແບບຂອງທ່ານເອງ 
e. What kind of things do you normally talk about when you interact with other villagers? โดยปกติเม่ือท่านพบปะกบั
ชาวบา้นคนอ่ืนๆ ท่านสนทนากนัเร่ืองอะไรบา้ง ໂດຍປົກກະຕິທ່ານພົບປະກັບຊາວບູ້ານຄົນອ ື່ນໆ ທ່ານລົມເລ ື່ອງຫຍັງແດ່ 
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6. I will now ask you a set of questions, regarding the people you interact with. ชุดค าถามต่อไปจะถามถึงบุคคลท่ีท่านพบปะพูดคุยดว้ย ຊຸດຄໍາຖາມຕ ໍ່ໄປຈະຖາມເຖິງບຸກຄົນທີື່ທ່ານພົບປະໂອູ້ລົມນໍາ 
 
With whom do you interact on a regular basis? โดยปกติในชีวิตประจ าวนัท่านพบปะพูดคุยกบัใครบา้ง ໂດຍປົກກະຕິໃນຊິວິດປະຈໍາວັນທ່ານພົບປະໂອູ້ລົມກັບໃຜແດ່ 








b) How is this person 




[give examples if respondent 














d) Where does 
this person live? 
ท่ีอยู ่ທີື່ຢ ູ່













f) How often do you 













[Mark all that 
apply] [ตอบได้มากกว่า 
1 ตัวเลือก] [ຕອບໄດູ້
ຫ າຍກ່ວາ 1 ຕວົ
ເລ ອກ] 
h) How often do your 
conversations relate to 





[If respondent does not 
discuss health, then move 














[Mark all that apply] [ตอบได้มากกว่า 1 ตัวเลือก] [ຕອບໄດູ້ຫ າຍກ່












Spouse คู่สมรส ຄ ່ແຕ່ງດອງ........ 1 
Parent บิดามารดา ພ ໍ່ແມ່ ............. 2 
Child บุตร ລ ກ ....................... 3 
Sibling พี่นอ้ง ອູ້າຍນູ້ອງ ............ 4 
Other relative ญาติ ພີື່ນູ້ອງ ...... 5 
Neighbour เพื่อนบา้น ເພ ື່ອນບູ້ານ . 6 
Friend (if not neighbour) เพื่อน 
(ท่ีไม่ใช่เพื่อนบา้น) ໝ ່ (ທີື່ບ ໍ່ແມ່ນເພ ື່ອນ
ບູ້ານ) .................................. 7 
Other villager ชาวบา้นคนอ่ืนๆ 
ຊາວບູ້ານຄົນອ ື່ນໆ .................... 8 
Other (specify) อ่ืนๆ (โปรดระบุ) 
ອ ື່ນໆ (ກະລຸນາບອກ) _ ............. 9 
Female.. 1 
หญิง ຍິງ 
Male ..... 2 
ชาย ຊາຍ 
 






















Daily or more often ทุกวนัหรือ
บ่อยกว่า ທຸກມ ົ້ຫ  ໜູ້ອຍກ່ວາ ......... 4 
Weekly or few times/week 
ทุกสปัดาห์หรือมากกว่าหน่ึงคร้ังต่อสปัดาห์ 
ທຸກອາທິດຫ  ຫ າຍກ່ວາໜຶື່ງເທ ື່ອຕ ໍ່
ອາທິດ ................................ 3 
Monthly or few 
times/month ทุกเดือนหรือมากกว่า
หน่ึงคร้ังต่อเดือน  
ທຸກເດ ອນຫ  ຫ າຍກ່ວາໜຶື່ງເທ ື່ອຕໍາ
ເດ ອນ................................. 2 
Yearly or few times/year ทุก
ปีหรือมากกว่าหน่ึงคร้ังต่อปี ທຸກປີຫ  ຫ າຍ
ກວ່າໜຶື່ງເທ ື່ອຕ ໍ່ປີ .................... 1 
Face-to-face ตวัต่อ
ตวั ໂຕຕ ໍ່ໂຕ ........... 1 
Voice call โทรศพัท ์




ໃຊູ້ອິນເຕີເນັດ ....... 3 
Other (specify) 
อ่ืนๆ (โปรดระบุ) ອ ື່ນໆ 
(ກະລຸນາບອກ)  
_____ .............. 4 
Always (100%) เป็นประจ า 
(100%) ເປັນປະຈໍາ (100%) .. 5 
Nearly always (<100%) เกือบ
เป็นประจ า (<100%) ເກ ອບເປັນປະ
ຈໍາ (<100%) ..................... 4 
Often (<90%) บ่อยคร้ัง (<90%) 
ບ່ອຍ (<90%) ...................... 3 
Sometimes (<50%) บางคร้ัง 
(<50%) ບາງຄັົ້ງ (<50%) ........ 2 
Hardly ever (<10%) แทบไม่เคย 
(<10%) ເກ ອບບ ໍ່ເຄີຍ (<10%) . 1 
Never (0%) ไม่เคยเลย (0%)....  ບ ໍ່
ເຄີຍເລີຍ........................... 0 
 [go to next contact] 
[ข้ามไปบคุคลต่อไป] [ຂູ້າມໄປບຸກຄນົ
ຕ ໍ່ໄປ]  
 
Talk about general well-being ไถ่ถามสารทุกขสุ์กดิบทัว่ไป 
ຖາມກ່ຽວກັບການເປັນຢ ູ່ທົັ່ວໄປ .................................... 1 
Update on health knowledge/newsอพัเดทเร่ืองความรู้หรือ
ข่าวสารสุขภาพใหม่ๆ  
ອັບເດດເລ ື່ອງຄວາມຮ ູ້ຫ  ຂ່າວສານສຸຂະພາບໃໝ່ໆ ................. 2 
Update on personal health status ..................... 
อพัเดทเร่ืองสุขภาพส่วนตวั ອັບເດດເລ ື່ອງສຸຂະພາບສ່ວນຕົວ .......... 3 
Advice on diagnosis ใหค้  าแนะน าเก่ียวกบัการวินิจฉยั  
ໃຫູ້ຄໍາແນະນໍາກ່ຽວກັບການວິເຄາະພະຍາດ......................... 4 
Advice on doctors ใหค้  าแนะน าเก่ียวกบัแพทย ์ 
ໃຫູ້ຄໍາແນະນໍາກ່ຽວກັບໝ ໍ............................................ 5 
Advice on treatment/medicine ใหค้  าแนะน าเก่ียวกบัวิธีการ
รักษา/ยา ໃຫູ້ແນະນໍາກ່ຽວກັບວິທີຮັກສາ/ຢາ ........................ 6 
OxTREC reference: 528-17 ANTIBIOTICS AND ACTIVITY SPACES 
20 June 2017. Version No: 2.0                                        Page 5 of 17 
Less often or never ไมค่่อยบ่อย
หรือไม่เคยเลย ບ ໍ່ເຄີຍເລີຍ ............. 0 
Emotional support/reassure ใหก้  าลงัใจ ใหค้วามมัน่ใจ ໃຫູ້ກໍາ
ລັງໃຈ ໃຫູ້ຄວາມໝັົ້ນໃຈ ............................................ 7 
Provide help during illness ใหค้วามช่วยเหลือระหว่างการป่วย 
ໃຫູ້ຄວາມຊ່ວຍເຫ  ອຕອນບ ໍ່ສະບາຍ ................................. 8 

























1  2  3  4  5  6  7  8  9 1  2 1  2 Name ช่ือ ຊ ື່ 0  1  2  3  4 1  2  3  4 0  1  2  3  4  5 1  2  3  4  5  6  7  8  9 
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a. How did you go about answering these questions? ท่านมีวิธีการตอบค าถามเหล่าน้ีอยา่งไร ທ່ານມີວິທີການຕອບຄໍາຖາມເຫ ົັ່ານີົ້
ແນວໃດ 
b. What did you imagine while answering the question, e.g. the “interaction setting” that you had in mind?  
ในขณะท่ีท่านตอบค าถามเหล่าน้ีท่านมีภาพอะไรอยูใ่นใจ เช่น ลกัษณะของสถานท่ี ฯลฯ  ໃນຂະນະທີື່ທ່ານຕອບຄໍາຖາມເຫ ົັ່ານີົ້ທ່ານມີພາບຫຍັງຢ ູ່ໃນໃຈ 
ເຊັັ່ນ ລັກຊະນະຂອງສະຖານທີື່ ແລະອ ື່ນໆ 
c. What time period were you thinking of? จากค าตอบท่ีท่านใหเ้ราเก่ียวกบับุคคลท่ีท่านมีปฏิสมัพนัธ์ดว้ย ท่านนึกถึงช่วงเวลาใด ຈາກຄໍາຕອບ
ທີື່ທ່ານໃຫູ້ເຮົາກ່ຽວກັບບຸກຄົນທີື່ທ່ານມີປະຕິສໍາພັນນໍາ ທ່ານນຶກເຖິງຊ່ວງເວລາໃດ 
d. How did you come up with the order of people? Why did you think of these people first rather than others? 
ท่านมีการเรียงล าดบับุคคลเหล่าน้ีอยา่งไร เพราะเหตุใดท่านจึงบอกช่ือบุคคลเหล่าน้ีกบัเราเป็นล าดบัแรกๆ หากเปรียบเทียบกบับุคคลอ่ืน  ທ່ານມີການລຽງລໍາດັບ
ບຸກຄົນເຫ ົັ່ານີົ້ແບບໃດ ຍູ້ອນຫຍັງທ່ານຈຶື່ງບອກຊ ື່ບຸກຄົນເຫ ົັ່ານີົ້ກັບກ່ອນຄົນອ ື່ນ 
e. What is the best way we can find these people from your interaction circle? How would you describe 
where they live? หากเราตอ้งการพูดคุยกบับุคคลท่ีท่านกล่าวถึงเหล่าน้ี เราสามารถพบพวกเขาไดอ้ยา่งไร ท่านจะสามารถอธิบายท่ีอยูข่องพวกเขาได้
อยา่งไร  ຖູ້າເຮົາຕູ້ອງການລົມກັບບຸກຄົນທີື່ທ່ານກ່າວເຖິງເຫ ົັ່ານີົ້ ເຮົາສາມາດພົວພັນພວກເຂົາໄດູ້ແນວໃດ ທ່ານສາມາດອະທິບາຍທີື່ຢ ູ່ຂອງພວກ
ເຂົາໄດູ້ແນວໃດ 
Part IV – Health-Related Survey Questions ส่วนที ่4 – ค าถามเกีย่วกบัสุขภาพ ສວ່ນທີື່ 4 -  ຄາໍຖາມກຽ່ວກບັສຂຸະພາບ 
Thank you for this. Now we come to a part where I will ask you some questions about health and health providers 
around here. ขอบคุณครับ/ค่ะ ค าถามช่วงต่อไปจะเป็นเร่ืองสุขภาพและสถานบริการสุขภาพในพืน้ท่ีนี ้ຂອບໃຈ ຄໍາຖາມຕ ໍ່ໄປນີົ້ຈະເປັນຄໍາຖາມກ່ຽວກັບສຸຂະພາບ
ແລະສະຖານບ ລິການສຸຂະພາບໃນພ ົ້ນທີື່ນີົ້ 
7. For the following question, can you please “think out loud” about your answers? เราขอใหท่้าน “คิดออกเสียง” ในระหวา่งท่ี
ท่านตอบค าถามต่อไปน้ี ເຮົາຂ ໃຫູ້ທ່ານ “ຄິດອອກສຽງ” ໃນລະຫ່ວາງການຕອບຄໍາຖາມຕ ໍ່ໄປນີົ້ 
I would now like to ask you about 
the sources of health advice and 
medicine or other treatment that 
are available to you. Please think 
about all the places where you 
can go to get advice, treatment, or 
drugs if you (or your children) are 
sick. ค าถามต่อไปเป็นค าถามเก่ียวกบัสถานท่ีหรือ
บุคคลท่ีท่านสามารถรับค าปรึกษา รับยา หรือ รับการรักษา
อ่ืนๆ ได ้กรุณานึกถึงสถานท่ีทุกแห่งหรือคนทุกคนท่ีท่าน
สามารถรับค าปรึกษา รับการรักษา หรือรับยา หากทา่น
หรือเดก็ในปกครองของท่านป่วย ຄໍາຖາມຕ ໍ່ໄປ
ເປັນຄໍາຖາມກ່ຽວກັບສະຖານທີື່ຫ  ບຸກຄົນທີື່
ທ່ານສາມາດຮັບຄໍາປຶກສາ ຮັບຢາ ຫ  ຮັບການ
ຮັກສາອ ື່ນໆ ໄດູ້ ກະລຸນານຶກເຖິງສະຖານທີື່ທຸກ
ແຫ່ງຫ  ບຸກຄົນທຸກຄົນທີື່ທ່ານສາມາດຮັບຄໍາ
ປຶກສາ ຮັບການຮັກສາ ຫ  ຮັບຢາ ຖູ້າຫາກທ່ານ
ຫ  ເດັກທີື່ທ່ານດ ແລບ ໍ່ສະບາຍ 
 
Which of the following options do 
you consider for medical 
treatment, advice, or to get 
medicine? ท่านเคยไดรั้บค าปรึกษา รับยา หรือ รับ
Drug dispensary, 





Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
Traditional healer หมอ
ชาวบา้น ໝໍຊາວບູ້ານ 
Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
Pharmacist เภสชักร ຜ ູ້
ຂາຍຢາ 
Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
Private clinic คลินิกเอกชน 
ຄລິນິກເອກະຊົນ 
Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
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การรักษา จากใครบา้ง ທ່ານເຄີຍໄດູ້ຮັບຄໍາປຶກສາ 
ຮັບຢາ ຫ  ຮັບການຮັກສາອ ື່ນຈາກໃຜແດ່ 
 
[Mark all that apply] [ตอบได้มากกว่า 1 




Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
Primary care unit สถานี
อนามยัของรัฐ ສະຖານີອານາໄມ
ຂອງລັດ 
Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
Public hospital โรงพยาบาล
รัฐ ໂຮງໝໍລັດ 
Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
Other providers or 
Internet? Specify: ผู้
ให้บริการรูปแบบอ่ืนๆ หรือ
อินเตอร์เน็ต (โปรดระบ)ุ ຜ ູ້
ບ ລິການໃນຮ ບແບບອ ື່ນໆຫ  
ອິນເຕີເນັດ (ກະລຸນາບອກ) 
_________ 
Medical treatment เพ่ือการรักษา ສໍາລັບການປ ິ່ນປົວ ............................................ 1 
Medical advice เพ่ือค าแนะน าในการรักษา ສໍາລັບຄໍາແນະນໍາໃນການປ ິ່ນປົວ .................... 2 
Access to medicine เพ่ือซ้ือ/รับยา ສໍາລັບຊ ົ້/ຮັບຢາ ............................................ 3 
Don’t consider this provider ไม่มีการใชบ้ริการประเภทน้ี ບ ໍ່ມີການໃຊູ້ບ ລິການປະເພດນີົ້ .. 0 
Don’t know such a provider ไม่รู้จกัผูใ้ห้บริการประเภทน้ี ບ ໍ່ຮ ູ້ຈັກຜ ູ້ໃຫູ້ບ ລິການປະເພດນີົ້ . 99 
 
a. Do you choose any of these providers for specific symptoms or illnesses? ท่านมีการเลือกสถานบริการสุขภาพแห่งใดแห่ง
หน่ึงส าหรับรักษาโรคใดโดยเฉพาะหรือไม่ ທ່ານມີການເລ ອກສະຖານສຸຂະພາບທີື່ໃດທີື່ຫນຶື່ງສໍາລັບກວດພະຍາດໃດໂດຍສະເພາະຫ  ບ ໍ່
b. Do you think these questions are too hard? ท่านรู้สึกวา่ค าถามเหล่าน้ียากเกินไปหรือไม่ ທ່ານຮ ູ້ສຶກວ່າຄໍາຖາມເຫ ົັ່ານີົ້ຍາກເກີນໄປຫ  ບ ໍ່
c. How big of an area do you think of when you answered these questions? E.g. within the village, the 
province, the surrounding provinces ในขณะท่ีท่านตอบค าถามเหล่าน้ี ท่านนึกถึงสถานบริการสุขภาพภายในบริเวณใด เช่น ภายในหมู่บา้น 
ภายในจงัหวดั หรือรวมจงัหวดัรอบนอกดว้ย ຕອນທີື່ທ່ານຕອບຄໍາຖາມເຫ ົັ່ານີົ້ ທ່ານນຶກເຖິງສະຖານທີື່ບ ລິການສຸຂະພາບພາຍໃນບ ລິເວນໃດ ເຊັັ່ນ 
ພາຍໃນໝ ່ບູ້ານ ພາຍໃນແຂວງ ຫ  ແຂວງຮອບນອກ 
d. Are there other forms of health provider that you could use but we have not talked about? มีสถานบริการสุขภาพ
ลกัษณะอ่ืนท่ีท่านสามารถใชบ้ริการไดแ้ต่เรายงัไมไ่ดพ้ดูถึงอีกหรือไม ่ມີສະຖານທີື່ບ ລິການສຸຂະພາບລັກຊະນະອ ື່ນທີື່ທ່ານສາມາດໃຊູ້ບ ລິການໄດູ້ແຕ່
ເຮົາຍັງບ ໍ່ໄດູ້ເວົົ້າເຖິງອີກຫ  ບ ໍ່
 
8. I will now ask you another series of questions regarding a recent illness. ต่อไปเราจะถามค าถามเก่ียวกบัอาการป่วยคร้ังล่าสุดของ
ท่าน  ຕ ໍ່ໄປນີົ້ເຮົາຈະຖາມຄໍາຖາມກ່ຽວກັບການເຈັບເປັນຄັົ້ງລ່າສຸດຂອງທ່ານ 
Did you have an acute illness (not a chronic, long-term condition that 
comes again and again) or an accident in the last two months? ในช่วงสอง
เดือนท่ีผา่นมา ท่านมีอาการป่วย (ไม่รวมโรคเร้ือรังหรือโรคท่ีเป็นๆ หายๆ) หรือประสบอุบติัเหตุ หรือไม่ ໃນຊ່ວງສອງ
ເດ ອນທີື່ຜ່າມມາ ທ່ານມີອາການເຈັບເປັນ (ບ ໍ່ລວມພະຍາດຊໍາເຮ ົ້ອຫ  ພະຍາດທີື່ເປັນຕ ໍ່ເນ ື່ອງ) ຫ  
ອຸປະຕິເຫດຫ  ບ ໍ່? 
No ไม่ใช่ ບ ໍ່ແມ່ນ ......... 2  
Yes ใช่ ແມ່ນ ............. 1 
 
[if yes:] [ถ้าใช่:] [ຖູ້າແມ່ນ:] Description of condition: ค าอธิบายอาการ ຄໍາອະທິບາຍອາການ 
__________________________________________ 
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Can you please describe the symptoms or problem in your 
own words? กรุณาอธิบายอาการหรือปัญหาในแบบท่ีท่านเขา้ใจ ກະລຸນາອະທິບາຍ
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Can you please describe the diagnosis of the illness if you 
received any and where you received it? 
 
[note: the diagnosis might be given by any medical provider 
including untrained and informal. Record all diagnoses if more than 
one.] หากท่านไดรั้บการวินิจฉยัอาการ กรุณาอธิบายการวินิจฉยันั้นและระบุแหล่งท่ีมา [หมายเหตุ: ผูใ้ห้
สมัภาษณ์อาจไดรั้บการวินิจฉยัจากผูใ้ห้บริการทางสุขภาพลกัษณะใดก็ได ้ซ่ึงรวมถึงผูใ้ห้บริการท่ีไม่รับการศึกษา
ดา้นการแพทยแ์ละผูใ้ห้บริการนอกระบบ กรอกขอ้มูลการวินิจฉยัทั้งหมด หากผูใ้ห้สมัภาษณ์ไดรั้บการวินิจฉยั
มากกว่า 1 คร้ัง] ຖູ້າຫາກທ່ານໄດູ້ຮັບການວິເຄາະພະຍາດ ກະລຸນາອະທິບາຍການວິເຄາະ
ພະຍາດເທ ື່ອນັົ້ນແລະລະບຸແຫ ່ງຂ ໍ້ມ ນ [ຫມາຍເຫດ: ຜ ູ້ໃຫູ້ສໍາພາດອາດໄດູ້ຮັບການວິເຄາະ
ພະຍາດຈາກຜ ູ້ໃຫູ້ບ ລິການສຸຂະພາບປະເພດໃດກ ໍ່ໄດູ້ ເຊິື່ງຮວມເຖິງຜ ູ້ໃຫູ້ບ ລິການສຸຂະພາບທີື່
ບ ໍ່ມີການສຶກສາທາງການແພດແລະຜ ູ້ໃຫູ້ບ ລິການນອກລະບົບ ຕ ື່ມໃສ່ຂ ໍ້ມ ນການວິເຄາະ
ພະຍາດທັງຫມົດ ຖູ້າຜ ູ້ໃຫູ້ສໍາພາດໄດູ້ຮັບການວິເຄາະພະຍາດຫ າຍກ່ວາ 1 ຄັົ້ງ] 
 
[Response codes รหสัค าตอบ ລະຫັດຄໍາຕອບ] 
Drug dispensary, other local store selling medicine  
ร้านขายของช าหรือร้านคา้ทัว่ไปท่ีมีการจ าหน่ายยา ຮູ້ານທົັ່ວໄປທີື່ມີການຂາຍຢາ .................... 1 
Traditional healer หมอชาวบา้น ໝໍຊາວບູ້ານ ............................................ 2 
Pharmacist เภสชักร ຜ ູ້ຂາຍຢາ .............................................................. 3 
Private clinic คลินิกเอกชน ຄລິນິກເອກະຊົນ ............................................... 4 
Private hospital โรงพยาบาลเอกชน ໂຮງໝໍເອກະຊົນ ..................................... 5 
Primary care unit สถานีอนามยัของรัฐ ສະຖານີອານາໄມຂອງລັດ ....................... 6 
Public hospital โรงพยาบาลรัฐ ໂຮງໝໍລັດ ................................................. 7 
Other providers or Internet? Specify: ผูใ้ห้บริการรูปแบบอ่ืนๆ หรืออินเตอร์เน็ต (โปรด
ระบุ) ຜ ູ້ບ ລິການໃນຮ ບແບບອ ື່ນໆຫ  ອິນເຕີເນັດ (ກະລຸນາບອກ) ________ ........... 8 
Diagnosis 1 การวินิจฉยัโรค 1 ການວິເຄາະພະຍາດ 1: 
__________________________________________ 
 
Medical provider 1 ผูใ้ห้บริการทางสุขภาพ 1 ຜ ູ້ໃຫູ້ບ ລິການສຸຂະພາບ 1:  
1  2  3  4  5  6  7  8 
 
 
Diagnosis 2 การวินิจฉยัโรค 2 ການວິເຄາະພະຍາດ 2: 
__________________________________________ 
 
Medical provider 2 ผูใ้ห้บริการทางสุขภาพ 2 ຜ ູ້ໃຫູ້ບ ລິການສຸຂະພາບ 2:  
1  2  3  4  5  6  7  8 
 
 
Diagnosis 3 การวินิจฉยัโรค 3 ການວິເຄາະພະຍາດ 3: 
__________________________________________ 
 
Medical provider 3 ผูใ้ห้บริการทางสุขภาพ 3 ຜ ູ້ໃຫູ້ບ ລິການສຸຂະພາບ 3:  
1  2  3  4  5  6  7  8 
 
When did you experience the accident/discomfort (for the 
first time) ท่านเร่ิมมีอาการป่วยหรือประสบอุบติัเหตุตั้งแต่เม่ือใด ທ່ານເລີື່ມມີອາການ
ເຈັບເປັນຫ  ຖ ກອຸບັດຕິເຫດຕັົ້ງແຕ່ເມ ື່ອໃດ? 
Onset: ___ days / ______ weeks / _____ months ago 
เร่ิมอาการป่วย/อุบติัเหตุ: ______ วนั / ______ สปัดาห์ / _____ เดือนท่ีแลว้ 
ເລີື່ມມີອາການບ ໍ່ສະບາຍຫ  ອຸບັດຕິເຫດ: ___ ມ ົ້ / ___ ອາທິດ / ___ ເດ ອນກ່ອນ 
 
Would you describe the illness/accident as “mild,” 
“moderate,” or “severe”? ท่านคิดวา่การป่วยหรืออุบติัเหตุคร้ังนั้นอยูใ่นขั้นนอ้ย ปาน
กลาง หรือหนกั ທ່ານຄິດວ່າອາການເຈັບເປັນຫ  ອຸບັດຕະເຫດຄັົ້ງນັົ້ນຢ ູ່ຂັົ້ນນູ້ອຍ, ປານ
ກາງ, ຫ  ໜັກ 
Mild นอ้ย ນູ້ອຍ .................................... 1  
Moderate ปานกลาง ປານກາງ ................ 2  
Severe หนกั ໜັກ ............................... 3  
 
 
a. Did you feel comfortable talking about your health? ท่านรู้สึกสบายใจ (หรืออึดอดัใจ) ในการพูดคุยเร่ืองสุขภาพหรือไม่ ທ່ານຮ ູ້ສຶກ
ສະບາຍໃຈ (ຫ  ອຶດອັດໃຈ) ໃນການລົມເລ ື່ອງສຸຂະພາບຫ  ບ ໍ່
b. Do you think these questions are too hard? ท่านรู้สึกวา่ค าถามเหล่าน้ียากเกินไปหรือไม่ ທ່ານຮ ູ້ສຶກວ່າຄໍາຖາມເຫ ົັ່ານີົ້ຍາກເກີນໄປຫ  ບ ໍ່
c. How do you rank mild, moderate, and severe? What do those words mean to you? ท่านใชอ้ะไรเป็นเคร่ืองบ่งบอกวา่
อาการป่วยของท่านนอ้ย ปานกลาง หรือหนกั, ในความคิดของท่าน นอ้ย ปานกลาง และหนกั หมายความวา่อยา่งไร ທ່ານໃຊູ້ຫຍັງເປັນເຄ ື່ອງບົັ່ງບອກອາການ
ເຈັບເປັນຂອງທ່ານ ນູ້ອຍ ປານກາງ ຫ  ໜັກ, ໃນຄວາມຄິດຂອງທ່ານ ໜູ້ອຍ ປານກາງແລະໜັກ ໝາຍຄວາມວ່າແນວໃດ 
9. The next set of questions still relates to the same illness. ค าถามชุดต่อไปยงัคงเก่ียวกบัอาการป่วยคร้ังเดียวกบัค าถามก่อนหนา้ ຄໍາຖາມຊຸດຕ ໍ່
ໄປຍັງກ່ຽວກັບອາການບ ໍ່ສະບາຍເຊັັ່ນດຽວກັບຄໍາຖາມກ່ອນໜູ້ານີົ້ 
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Can you please explain the stages of the treatment? I will ask you step-by-step what you did, starting from the moment you first 
detected the condition. กรุณาอธิบายขั้นตอนการรักษาทุกขั้นตอนระหว่างการป่วยคร้ังน้ี เราขอให้ท่านเล่าให้เราฟังทีละขั้นตอนตั้งแต่ท่านเร่ิมรู้สึกมีอาการป่วย ກະລຸນາອະທິບາຍຂັົ້ນຕອນການປົວ
ທຸກຂັົ້ນຕອນລະຫ່ວາງການເຈັບເປັນຄັົ້ງນີົ້ ເຮົາຂ ໃຫູ້ທ່ານເລົັ່າໃຫູ້ເຮົາຟັງເທ ື່ອລະຂັົ້ນຕອນຕັົ້ງແຕ່ຕອນທີື່ທ່ານເລີື່ມມີອາການບ ໍ່ສະບາຍ 
 
[ask respondent what he or she did first, then code answer and continue. After each column, ask: “What did you do next?” Only 
one activity per step. If e.g. medical treatment and then home care, first step is medical treatment, second step is home care. 
Repeat until respondent was cured or today otherwise.] [ถามค าถามเกี่ยวกับข้ันตอนการรักษาข้ันแรกสุด จากน้ันกรอกรหัสค าตอบ แล้วจงึถามค าถามต่อไป หลังจากกรอกข้อมูลในแต่
ละคอลัมน์ ให้ถาม “ท่านท าอะไรต่อไปหลังจากน้ัน” กรอกข้อมูลของการรักษาแต่ละชนิดต่อหน่ึงข้ันตอนเท่าน้ัน ตัวอย่าง: “เข้าพบแพทย์แล้วรักษาอาการที่บ้าน” ให้กรอก ขั้นที่ 1 เข้าพบแพทย์ และขั้นที่ 2 รักษาอาการ
ที่บ้าน บันทึกข้ันตอนทุกข้ันตอนเช่นน้ีจนถึงข้ันที่หายจากอาการหรือจนถึงวันที่ท าการเก็บข้อมูล] [ຖາມຄາໍຖາມກຽ່ວກບັຂັົ້ນຕອນການປ ິ້ນປວົຂັົ້ນທາໍອດິ ຈາກນັົ້ນຂຽນລະຫດັຄາໍຕອບ ແລູ້ວຈຶື່ງ
ຖາມຄາໍຖາມຕ ໍ່ໄປ ຫ ງັຈາກຂຽນຂ ໍ້ມ ນໃນແຕລ່ະຫູ້ອງ ໃຫູ້ຖາມ “ທາ່ນເຮດັຫຍັງຕ ໍ່ໄປຫ ງັຈາກນັົ້ນ” ຂຽນຂ ໍ້ມ ນຂອງການປ ິ່ນປວົແຕລ່ະຊະນດິຕ ໍ່ໜຶື່ງຂັົ້ນຕອນເທົັ່ານັົ້ນ ຕວົຢູ່າງ: “ເຂົົ້າພບົ
ໝໍແລູ້ວປ ິ່ນປວົອາການຢ ູ່ເຮ ອນ” ໃຫູ້ຂຽນຂັົ້ນທີື່ 1 ເຂົົ້າພບົໝໍ ແລະຂັົ້ນທີື່ 2 ປວົອາການຢ ູ່ເຮ ອນ ບນັທກຶຂັົ້ນຕອນທກຸຂັົ້ນຕອນແບບນີົ້ຈນົເຖງິຂັົ້ນທີື່ດຈີາກອາການຫ  ຈນົຮອດມ ົ້ເກບັ
ຂ ໍ້ມ ນ] 
 Step 1 (detection)  
ขั้นท่ี 1 (เม่ือเร่ิมรู้สึกป่วย)  





[continue until Step x when 





ເປັນຈນົເຖງິຫາຍດຫີ  ຈນົຮອດມ ົ້ເກບັຂ ໍ້
ມ ນ] 
a) What kind of help or treatment did 
you get at this stage? ท่านมีการรักษาในขั้นตอน
น้ีอยา่งไร ທ່ານມີການປ ິ່ນປົວໃນຂັົ້ນຕອນນີົ້ແບບໃດ 
 
[if unsure, specify] [หากไม่มั่นใจ ให้กรอก
รายละเอียดในหมวด “อืน่ๆ”] [ຖູ້າບ ໍ່ໝັົ້ນໃຈໃຫູ້ຂຽນ
ລາຍລະອຽດໃນໝວດ “ອ ື່ນໆ”] 
 
Ignored /did nothing ละเลย/ไม่ท าอะไร ບ ໍ່ສົນໃຈ/ບ ໍ່ເຮັດຫຍັງເລີຍ . 1 
Self-care (sleep, rest, medicine at home) รักษาตวัเอง (นอน
หลบั, พกัผอ่น, ใชย้าท่ีมีท่ีบา้น) ປົວຕົນເອງ (ນອນ, ພັກຜ່ອນ, ໃຊູ້ຢາທີື່ມີຢ ູ່
ເຮ ອນ) ......................................................................... 2 
Care from family and friends (full-time) ไดรั้บการรักษาจาก
ครอบครัวหรือเพ่ือน (ตลอดเวลา) ໄດູ້ຮັບການປ ິ່ນປົວຈາກຄອບຄົວຫ  ໝ ່
(ຕະຫ ອດເວລາ) ............................................................... 3 
Treated/consulted at a pharmacist รับการรักษา/ค าปรึกษาจาก
เภสชักร ຮັບການປ ິ່ນປົວ/ຄໍາປຶກສາຈາກຜ ູ້ຂາຍຢາ .......................... 4 
Treated/consulted at shop selling drugs รับการรักษา/
ค าปรึกษาจากร้านขายของช าหรือร้านคา้ทัว่ไปท่ีมีการจ าหน่ายยา ຮັບການປ ິ່ນປົວ/ຄໍາ
ປຶກສາຈາກຮູ້ານທົັ່ວໄປທີື່ມີການຂາຍຢາ ................................... 5 
Treated/consulted at priv. clinic/hospital รับการรักษา/
ค าปรึกษาจากคลินิก/โรงพยาบาลเอกชน ຮັບການປ ິ່ນປົວ/ຄໍາປຶກສາຈາກຈາກຄລິ
ນິກ/ໂຮງໝໍເອກະຊົນ ......................................................... 6 
Treated/consulted at primary care unit รับการรักษา/ค าปรึกษา
จากสถานีอนามยัของรัฐ ຮັບການປຶິ່ນປົວ/ຄໍາປຶກສາຈາກສະຖານີອານາໄມ
ຂອງລັດ ........................................................................ 7 
Treated/consulted at a gvt. Hospital รับการรักษา/ค าปรึกษาจาก
โรงพยาบาลของรัฐ ຮັບການປຶິ່ນປົວ/ຄໍາປຶກສາຈາກຈາກໂຮງໝໍຂອງລັດ ... 8 
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b) Where did this activity take place? 
ขั้นตอนการรักษาน้ีเกิดข้ึนท่ีไหน ຂັົ້ນຕອນການປ ິ່ນປົວນີົ້
ເກີດຂ ົ້ນຢ ູ່ໄສ 
At home ท่ีบา้น ຢ ູ່ເຮ ອນ ................................................... 1 
Less than 10 min. from home นอ้ยกว่า 10 นาทีจากบา้น ນູ້ອຍກ່
ວາ 10 ນາທີຈາກເຮ ອນ ..................................................... 2 
10 to 29 min. 10 ถึง 29 นาทีจากบา้น 10 ຫາ 29 ນາທີຈາກເຮ ອນ
 .................................................................................. 3 
30 to 59 min. 30 ถึง 59 นาทีจากบา้น 30 ຫາ 59 ນາທີຈາກເຮ ອນ
 .................................................................................. 4 
60 to 119 min. 60 ถึง 119 นาทีจากบา้น 60 ຫາ 119  
ນາທີຈາກເຮ ອນ ............................................................... 5 
2 hours or more from home 2 ชัว่โมงหรือมากกว่านั้น ສອງ


















[select “at home” according to prior 
responses เลือก “ที่บ้าน” ให้สอดคล้องกับค าตอบก่อน
หน้าหากเข้าข่ายกรณีน้ัน] [ເລ ອກ “ຢ ູ່ເຮ ອນ” ໃຫູ້
ສອດຄອ່ງ ກບັຄາໍຕອບກອ່ນໜູ້າຫາກກຽ່ວຂູ້ອງກນັ] 
At home ท่ีบา้น ຢ ູ່ເຮ ອນ ................................................... 1 
Walk เดินเทา้ ຍ່າງ ............................................................ 2 
Own bicycle จกัรยานของท่าน ລົດຖີບຂອງທ່ານ ........................ 3 
Own motorcycle / Three-wheeler รถจกัรยานยนต/์รถสามลอ้ของ
ท่านລົດຈັກ/ລົດສາມລ ໍ້ຂອງທ່ານ ............................................ 4 
Own car / four-wheeler รถยนต/์ขบัเคล่ือนส่ีลอ้ของท่าน ລົດຢົນ/ລົດ
ໃຫຍ່ສີື່ລ ໍ້ຂອງທ່ານ ............................................................ 5 
Taxi or other hired ride รถแทก็ซ่ี/รถรับจา้ง ລົດເທັກຊີ/ລົດຮັບຈູ້າງ
 .................................................................................. 6 
Public transport ขนส่งสาธารณะ ລົດຂົນສົັ່ງສາທາລະນະ .............. 7 





















[let respondent choose category; if less 
than one day, code “1” day] [ให้ผู้ให้สัมภาษณ์
เลือกหน่วยเวลาเอง หากน้อยกว่าหน่ึงวนัให้กรอก “1” วัน] 
[ໃຫູ້ຜ ູ້ໃຫູ້ສາໍພາດເລ ອກໜວ່ຍເວລາເອງ ຖູ້ານູ້ອຍກ່
ວາໜຶື່ງມ ົ້ໃຫູ້ຂຽນ “1” ມ ົ້] 
Duration ระยะเวลา ໄລຍະເວລາ:  
___ days วนั ມ ົ້
___ weeks สปัดาห์ ອາທິດ 
___ months เดือน ເດ ອນ 







เดือน ເດ ອນ 
 
___ days วนั ມ ົ້
___ weeks สปัดาห์ ອາທິດ 
___ months เดือน ເດ ອນ 
 
e) Why did you seek this 
advice/treatment? เพราะเหตุใดท่านจึงเลือกรักษา/
รับค าแนะน าน้ี ເປັນຫຍັງທ່ານຈຶື່ງເລ ອກການປ ິ່ນປົວ/
ຮັບຄໍາແນະນໍານີົ້ 
 
[Mark all that apply] [ตอบได้มากกว่า 1 ตัวเลือก] 
[ຕອບໄດູ້ຫ າຍກວ່າ 1 ຕວົເລ ອກ] 
 
This is the normal choice เป็นส่ิงท่ีท าอยูป่กติ ເປັນແນວປະຕິບັດ
ປົກກະຕິ ........................................................................ 1  
Advice from others เป็นค าแนะน าจากคนอ่ืน ເປັນຄໍາແນະນໍາຈາກຄົນ
ອ ື່ນ.............................................................................. 2 
Too busy for alternatives ไม่มีตวัเลือกอ่ืนเพราะไม่ว่าง ບ ໍ່ມີທາງເລ ອກ
ອ ື່ນເນ ື່ອງຈາກບ ໍ່ມີເວລາ ...................................................... 3 
No access to money/transportation มีปัญหาเร่ืองเงินหรือการ
เดินทาง ມີບັນຫາກ່ຽວກັບເງິນຫ  ການເດີນທາງ ............................. 4 
Ran out of medicines ยาท่ีใชอ้ยูห่มด ຢາທີື່ໃຊູ້ຍ ່ຫມົດ ............. 5 
Not feeling better พยายามรักษาดว้ยวิธีอ่ืนแลว้ไม่หาย ປ ິ່ນປົວໂດຍວິທີ
ອ ື່ນແລູ້ວບ ໍ່ດີຂ ົ້ນ ............................................................... 6 
New/more serious symptoms อาการหนกัลงกว่าเก่าหรือมีอาการอ่ืน
ปรากฏ ອາການຫນັກລົງກວ່າເກົັ່າຫ  ມີອາການອ ື່ນປາກົດເພີື່ມຂຶົ້ນ ........ 7 
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f) Can you please name or describe 
all the medicines that you received or 
were prescribed during this step? กรุณา
ระบุช่ือหรืออธิบายลกัษณะของยาทั้งหมดท่ีท่านไดรั้บจากการ
รักษาขั้นตอนน้ี ກະລຸນາບອກຊ ື່ຫ  ອະທິບາຍລັກສະນະ
ຂອງຢາທີື່ທ່ານໄດູ້ຮັບຈາກການປ ິ່ນປົວຂັົ້ນຕອນນີົ້ 
 
[leave blank if no medicine received] 
[include medicine stored at home if 
“self-care at home”] [continue for all 
medicines received, then complete 




สัมภาษณ์ได้รับ จากน้ันกรอกข้อมูลในค าถาม g ถึง k ส าหรับยา
แต่ละชนิด] [ຈົັ່ງຊອ່ງຫວ່າງຖູ້າຜ ູ້ໃຫູ້ສາໍພາດບ ໍ່ໄດູ້ຮບັ
ຢາຈາກການປ ິ່ນປວົໃນຂັົ້ນຕອນນີົ້]  [ຮວມຢາທີື່ມີ
ເກບັຢ ູ່ເຮ ອນດູ້ວຍ ຖູ້າຫາກຜ ູ້ໃຫູ້ສາໍພາດປວົຕນົເອງ
ຢ ູ່ເຮ ອນ] [ບນັທກຶຢາທກຸຊະນດິທີື່ຜ ູ້ໃຫູ້ສາໍພາດໄດູ້
ຮບັ ຈາກນັົ້ນຕ ື່ມຂ ໍ້ມ ນໃສໃ່ນຄາໍຖາມ g ເຖງິ k ສາໍ
ລບັຢາແຕລ່ະຊະນດິ] 
 
Medicine 1 ยาชนิดท่ี 1 ຢາຊະນິດທີື່ 1:  
Name/description ช่ือ/ค าอธิบาย ຊ ື່/ຄໍາອະທິບາຍ: 
_______________ 
Medicine 2 ยาชนิดท่ี 2 ຢາຊະນິດທີື່ 2:  
Name/description ช่ือ/ค าอธิบาย ຊ ື່/ຄໍາອະທິບາຍ: 
_______________ 
Medicine 3 ยาชนิดท่ี 3 ຢາຊະນິດທີື່ 3:  



























[for each medicine individually] [ส าหรับยา
แต่ละชนิด] [ສາໍລບັຢາແຕລ່ະຊະນດິ] 
 




[let respondent choose category; if 
more than one repeated episode, 
indicate total duration] [ให้ผู้ให้สัมภาษณ์เลือก
หน่วยเวลาเอง หากมีการใช้ยาตัวเดียวกันหลายคร้ัง ให้ผู้
สัมภาษณ์รวมระยะเวลาทั้งหมด] [ໃຫູ້ຜ ູ້ໃຫູ້ສາໍພາດເລ ອກ
ໜວ່ຍເວລາເອງ ຖູ້າມີການໃຊູ້ຕວົຢາຊະນດິດຽວກນັ
ຫ າຍເທ ື່ອໃຫູ້ຜ ູ້ສາໍພາດລວມໄລຍະເວລາທງັໝົດ] 
Duration ระยะเวลา ໄລຍະເວລາ: 
___ days วนั ມ ົ້
___ weeks สปัดาห์ ອາທິດ 









เดือน ເດ ອນ 
 
___ days วนั ມ ົ້
___ weeks สปัดาห์ ອາທິດ 
___ months เดือน ເດ ອນ 
 
h) How often per day did you take 
the medicine? ท่านใชย้าชนิดน้ีวนัละก่ีคร้ัง ທ່ານໃຊູ້
ຢາຊະນິດນີົ້ມ ລະຈັກເທ ື່ອ 
 
[calculate into daily use according to 
respondent’s chosen frequency]  
[ค านวณเป็นจ านวนคร้ังต่อวันจากค าตอบของผู้ให้สัมภาษณ์] 
[ຄດິໄລເ່ປນັຈາໍນວນເທ ື່ອຕ ໍ່ມ ົ້ຈາກຄາໍຕອບຂອງຜ ູ້ໃຫູ້
ສາໍພາດ] 




ເທ ື່ອຕ ໍ່ມ ົ້
 
___ times daily 
คร้ังต่อวนั ເທ ື່ອຕ ໍ່ມ ົ້
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i) What dosage did you normally 
take? ท่านใชย้าชนิดน้ีในปริมาณเท่าใดต่อหน่ึงคร้ัง 
ທ່ານໃຊູ້ຢາຊະນິດນີົ້ປະລິມານເທົັ່າໃດຕ ໍ່ໜຶື່ງເທ ື່ອ 
 
[let respondent choose category 
according to type of medicine] [ให้ผู้ให้
สัมภาษณ์เลือกหน่วยปริมาณยาเอง โดยข้ึนอยู่กับชนิดของยา] 
[ໃຫູ້ຜ ູ້ໃຫູ້ສາໍພາດເລ ອກໜວ່ຍປະລມິານຢາເອງ 
ໂດຍຂ ົ້ນຢ ູ່ກບັຊະນດິຂອງຢາ] 
Dosage ปริมาณ ຄວາມຖີື່: 
___ tablets / capsules 
เมด็/แคปซูล ເມັດ/ແຄບຊູນ 
___ drops (for liquid medicine) 
หยด (ส าหรับยาน ้า) ຢອດ (ສໍາລັບຢານໍໍ້າ) 
___ spoons (for liquid medicine) 
ชอ้น (ส าหรับยาน ้า) ບ່ວງ (ສໍາລັບຢານໍໍ້າ) 
 










___ tablets เมด็ ເມັດ 
___ drops หยด ຢອດ 
___ spoons ชอ้น ບ່ວງ 
 
j) Did you take the medicine exactly 
as it was recommended to you by the 
person who prescribed/sold them? 
ท่านใชย้าชนิดน้ีตามค าแนะน าของผูส้ัง่จ่าย/จ าหน่ายหรือไม่ 
ທ່ານໃຊູ້ຢາຊະນິດນີົ້ຕາມຄໍາແນະນໍາຈາກໝໍ/ຜ ູ້ຂາຍ
ຢາຫ  ບ ໍ່
Yes ใช่ ແມ່ນ .................................................................... 1 
No ไม่ใช่ ບ ໍ່ແມ່ນ................................................................. 2 
 
Did not receive advice ไม่ไดรั้บค าแนะน า  
ບ ໍ່ໄດູ້ຮັບຄໍາແນະນໍາ .............................................................. 9 









k) Did you finish the medicine? ท่านใชย้า
ชนิดน้ีจนหมดหรือไม่ ທ່ານໃຊູ້ຢາຊະນິດນີົ້ຈົນຫມົດຫ  ບ ໍ່
Yes ใช่ ແມ່ນ ............. 1 






Have you now recovered from the illness/accident? ท่านฟ้ืนตวัจากอาการป่วย/อุบติัเหตุแลว้หรือไม่ ທ່ານດີ
ຈາກອາການເຈັບເປັນ/ອຸບັດຕິເຫດແລູ້ວບ ໍ່? 
Yes ใช่ ແມ່ນ ............ 1 
No ไม่ใช่ ບ ໍ່ແມ່ນ ......... 2 
 
Was anybody of your personal relationships involved in providing advice or help during the illness? ท่านไดรั้บค าปรึกษาหรือความช่วยเหลือในดา้นใดๆ 
ก็ตามจากบุคคลท่ีเก่ียวขอ้งกบัท่านระหว่างการป่วยคร้ังน้ีหรือไม่ ທ່ານໄດູ້ຮັບຄໍາປຶກສາຫ  ຄວາມຊ່ວຍເຫ  ອໃນດູ້ານໃດໆ ກ ໍ່ຕາມຈາກບຸກຄົນທີື່ກ່ຽວຂູ້ອງກັບທ່ານລະຫ່ວາງການເຈັບເປັນຄັົ້ງນີົ້ຫ  
ບ ໍ່
 
[record up to ten names] [กรอกช่ือของบุคคลที่มีความเกี่ยวข้องระหว่างอาการป่วยไม่เกิน 10 คน] [ຂຽນຊ ື່ຂອງບກຸຄນົທີື່ມີຄວາມກຽ່ວຂອູ້ງລະຫວ່າງອາການເຈບັປູ່ວຍບ ໍ່ຫ າຍກວ່າ 10
ຄນົ] 






b) How is this person related to 
you? ความสมัพนัธ์กบัท่าน ຄວາມສໍາພັນກັບ
ທ່ານ? 
[give examples if respondent is 
unsure about answer categories] 
[หากผู้ให้สัมภาษณ์ไม่มั่นใจในหมวดค าตอบ ให้ยกตัวอย่าง
ค าตอบได้] [ຖູ້າຜ ູ້ໃຫູ້ສາໍພາດບ ໍ່ໝັົ້ນໃຈໃນໝວດຄາໍ
ຕອບ ໃຫູ້ຍົກຕວົຢູ່າງຄາໍຕອບໄດູ້] 
c) What kind of support was provided? ท่านได้รับความ
ช่วยเหลือจากบุคคลน้ีอย่างไร ທ່ານໄດູ້ຮັບການຊ່ວຍເຫ  ອຈາກບຸກຄົນເຫ ົັ່າ
ນີົ້ແນວໃດ? 
 
[mark all that apply] [ตอบได้มากกว่า 1 ตัวเลือก] [ຕອບໄດູ້ຫ າຍກ່
ວາ 1 ຕວົເລ ອກ] 
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Contact 1 คนท่ี 1 ຄົນທີື່ 1 
Name ช่ือ ຊ ື່: 
_______ 
Spouse คู่สมรส ຄ ່ແຕ່ງດອງ ..................1 
Parent บิดามารดา ພ ໍ່ແມ່ .......................2 
Child บุตร ລ ກ ..................................3 
Sibling พ่ีนอ้ง ອູ້າຍນູ້ອງ .......................4 
Other relative ญาติ ພີື່ນູ້ອງອ ື່ນໆ ...........5 
Neighbour เพ่ือนบา้น ເພ ື່ອນບູ້ານ ............6 
Friend (if not neighbour) เพ่ือน (ท่ีไม่ใช่
เพ่ือนบา้น) ໝ ່ (ທີື່ບ ໍ່ແມ່ນເພ ື່ອນບູ້ານ) ..........7 
Other villager ชาวบา้นคนอ่ืนๆ ຊາວບູ້ານ
ຄົນອ ື່ນໆ ..........................................8 
Other (specify) อ่ืนๆ (โปรดระบุ) ອ ື່ນໆ 
(ກະລຸນາບອກ) _ ...............................9 
Providing healthcare/attending ให้การรักษา/การดูแล 
ໃຫູ້ການເບິື່ງແຍງ ..................................................... 11 
Providing advice ให้ค าปรึกษา ໃຫູ້ຄໍາປຶກສາ ................. 12 
Providing medicine ให้ยา ໃຫູ້ຢາ ........................... 13 
 
Lending/granting money ให้หรือให้ยืมเงิน  
ໃຫູ້ຫ  ໃຫູ້ຢືມເງິນ ..................................................... 21 
Transportation/Lending vehicle อ านวยความสะดวกในดา้นการ
เดินทาง/ให้ยืมพาหนะ ສູ້າງຄວາມສະດວກດູ້ານການເດີນທາງ/ໃຫູ້ຢືມ
ຍານພາຫະນະ ........................................................ 22 
Contacting family/friends ติดต่อครอบครัว/เพ่ือน ຕິດຕ ໍ່
ຄອບຄົວ/ໝ ່ .......................................................... 23 
 
Providing food สนบัสนุนอาหาร  
 ສະຫນັບສະຫນຸນອາຫານ .......................................... 31 
Helping with children/housework ช่วยดูแลลูกหลาน/งานบา้น 
ຊ່ວຍເບິື່ງແຍງລ ກຫລານຫ  ເດັກນູ້ອຍ/ວຽກບູ້ານ ................. 32 
Helping with jobs/agriculture work (feeding 
animals/tending crops/covering shifts, etc.) ช่วยเหลือ




Other (specify) อ่ืนๆ (โปรดระบุ) ອ ື່ນໆ (ກະລຸນາບອກ) _ .. 99 
Contact 2 คนท่ี 2 ຄົນທີື່ 2 Name ช่ือ ຊ ື່ 1  2  3  4  5  6  7  8  9 11  12  13  21  22  23  31  32  33  99 
[continue until Contact x – 
maximum 10 contacts] [บนัทกึบุคคลที่มี
ความเกีย่วข้องระหว่างการเจบ็ป่วยทกุคน ไม่เกนิ 10 คน] 
[ບັນທຶກບຸກຄນົທີື່ມີຄວາມກ່ຽວຂອູ້ງລະຫ່ວາງ
ອາການເຈບັປູ່ວຍທຸກຄນົ ບ ໍ່ຫ າຍກ່ວາ 10ຄນົ] 
Name ช่ือ ຊ ື່ 1  2  3  4  5  6  7  8  9 11  12  13  21  22  23  31  32  33  99 
 
a. Do you think these questions are too hard? ท่านรู้สึกวา่ค าถามเหล่าน้ียากเกินไปหรือไม่ ທ່ານຮ ູ້ສຶກວ່າຄໍາຖາມເຫ ົັ່ານີົ້ຍາກເກີນໄປຫ  ບ ໍ່
b. Did you find it tedious to go through the illness in such detail? เป็นเร่ืองน่าเบ่ือหรือไม่ท่ีท่านตอ้งอธิบายอาการป่วยของท่านโดย
ละเอียด ເປັນເລ ື່ອງໜູ້າເບ ື່ອຫ  ບ ໍ່ທີື່ທ່ານຕູ້ອງມາອະທິບາຍອາການບ ໍ່ສະບາຍຂອງທ່ານຢູ່າງລະອຽດ 
c. How well do you remember the medicines that you used during that illness? ท่านสามารถจดจ ายาท่ีท่านใชร้ะหวา่งการ
ป่วยไดดี้เพยีงใด ທ່ານສາມາດຈ ື່ຢາທີື່ທ່ານໃຊູ້ລະຫ່ວາງຕອນເຈັບປູ່ວຍ ໄດູ້ດີພຽງໃດ 
d. Did you think about anything in particular to help you recall the medicines? ท่ีท่านนึกถึงอะไรเพื่อเป็นตวัช่วยในการ
ทวนความจ าเก่ียวกบัยาเหล่าน้ี ທ່ານນຶກເຖິງຫຍັງເປັນຕົວຊ່ວຍໃນການຈ ື່ກ່ຽວກັບຢາເຫ ົັ່ານີົ້ 
e. How do you indicate that the symptoms are cured? Would you stop taking medicines then? What if the 
doctor’s instruction is to complete the dose? ท่านสามารถบอกไดอ้ยา่งไรวา่อาการป่วยของท่านหายแลว้ หากอาการป่วยของท่านหายท่าน
จะหยดุรับประทานยาทนัทีหรือไม่ หากแพทยแ์นะน าใหท่้านใชย้าจนหมดแต่อาการของท่านหายแลว้ท่านยงัจะปฏิบติัตามค าสัง่แพทยห์รือไม่ ທ່ານສາມາດ
ບອກໄດູ້ແນວໃດວ່າອາການເຈັບເປັນຂອງທ່ານດີແລູ້ວ ຖູ້າອາການເຈັບເປັນຂອງທ່ານດີ ທ່ານຈະຢຸດກິນຢາທັນທີຫ  ບ ໍ່ ຖູ້າໝໍແນະນໍາໃຫູ້ທ່ານ
ໃຊູ້ຢາຈົນໝົດແຕ່ອາການຂອງທ່ານດີແລູ້ວທ່ານຍັງຈະປະຕິບັດຕາມຄໍາສັັ່ງໝໍຫ  ບ ໍ່
 
10. The next question deals with medicine. Could you please tell me what is going through your mind while you 
are answering the question? ค าถามต่อไปจะเป็นค าถามเก่ียวกบัยารักษาโรค เราขอใหท่้านบอกเราวา่ท่านนึกถึงอะไรระหวา่งการตอบค าถามเหล่าน้ี ຄໍາຖາມ
ຕ ໍ່ໄປຈະເປັນຄໍາຖາມກ່ຽວກັບຢາປົວພະຍາດ ເຮົາຂ ໃຫູ້ທ່ານບອກເຮົາວ່າທ່ານນຶກເຖິງຫຍັງລະຫ່ວາງການຕອບຄໍາຖາມເຫ ົັ່ານີົ້ 
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I would now like to ask you your opinion about medicine. There are no right or wrong answers, I only want to understand what 
you think. เราอยากทราบความคิดเห็นของท่านเก่ียวกบัการใชย้า ค าถามเหล่าน้ีไม่มีค าตอบท่ีถูกหรือผิด เราเพียงตอ้งการรู้ว่าท่านคิดอยา่งไร  ເຮົາຢາກຮ ູ້ຄວາມຄິດເຫັນຂອງທ່ານກ່ຽວກັບການໃຊູ້ຢາ ຄໍາ
ຖາມເຫ ົັ່ານີົ້ບ ໍ່ມີຄໍາຕອບຖ ກຫ  ຜິດ ເຮົາພຽງຕູ້ອງການຮ ູ້ວ່າທ່ານຄິດແນວໃດ 
 
Consider the following medicines – they are commonly referred to as “antibiotics.”  
พิจารณายาเหล่าน้ีซ่ึงเป็นยาท่ีถูกรู้จกัในนาม “ยาปฏิชีวนะ” ພິຈາລະນາຢາເຫ ົັ່ານີົ້ເຊິື່ງເປັນຢາທີື່ຮ ູ້ຈັກກັນໃນນາມ “ຢາຕູ້ານເຊ ົ້ອ” 
 
       
Would you buy this medicine if you think you need it but cannot get it prescribed by a 
doctor? หากท่านไม่ไดรั้บยาน้ีหลงัจากเขา้พบแพทยแ์มท้่านรู้สึกว่าท่านควรรับประทานยาน้ี ท่านจะซ้ือยาน้ีจากแหล่งอ่ืนหรือไม่ ຖູ້າທ່ານບ ໍ່ໄດູ້
ຮັບຢານີົ້ຫ ັງຈາກເຂົົ້າພົບໝໍເຖິື່ງທ່ານຈະຮ ູ້ສຶກວ່າທ່ານຄວນກິນຢານີົ້ ທ່ານຈະຊ ົ້ຢານີົ້ຈາກແຫ ່ງອ ື່ນຫ  ບ ໍ່
Yes ใช่ ແມ່ນ .......................................... 1 
No ไม่ใช่ ບ ໍ່ແມ່ນ ....................................... 2 
I don’t know ไม่ทราบ ບ ໍ່ຮ ູ້ ......................... 99 
Would you try other remedies such as sponge bath, herbs, or paracetamol before using 
this medicine? ท่านจะลองใชวิ้ธีการรักษาอ่ืน เช่น เชด็ตวั สมุนไพร หรือ พาราเซตามอลก่อนใชย้าน้ีหรือไม่ ທ່ານຈະພະຍາຍາມປ ິ່ນປົວ
ໂດຍວິທີການອ ື່ນ ເຊັັ່ນ ເຊັດຕັວ ຍາຮາກໄມູ້ ຫ  ພາຣາເຊຕາມອນກ່ອນໃຊູ້ຢານີົ້ຫ  ບ ໍ່
Yes ใช่ ແມ່ນ .......................................... 1 
No ไม่ใช่ ບ ໍ່ແມ່ນ ....................................... 2 
I don’t know ไม่ทราบ ບ ໍ່ຮ ູ້ ......................... 99 
If you had to take this medicine and your symptoms disappear after 2 days, would you 
finish a complete course of 7 days or stop taking it immediately? หากท่านจ าเป็นตอ้งรับประทานยาน้ี
และอาการของท่านดีข้ึนภายใน 2 วนั ท่านจะรับประทานยาต่อจนครบ 7 วนั หรือหยดุรับประทานทนัที ຖູ້າຫາກທ່ານມີຄວາມຈໍາເປັນຕູ້ອງ
ກິນຢານີົ້ເພ ື່ອການປ ິ່ນປົວ ແລະອາການຂອງທ່ານດີຂ ົ້ນພາຍໃນສອງມ ົ້ ທ່ານຈະກິນຢາຕ ໍ່ຈົນສຸດ 7 ມ ົ້ ຫ  ຢຸດກິນທັນທີ 
Finish course รับประทานต่อจนหมด  
ກິນຢາຕ ໍ່ຈົນສຸດ  ........................................ 1 
Stop taking หยดุรับประทาน ຢຸດກິນທັນທີ ........ 2 
I don’t know ไม่ทราบ ບ ໍ່ຮ ູ້ ......................... 99 
Do you think the way other people use this medicine affects its efficacy on you? ท่านคิดว่า
การใชย้าน้ีของคนอ่ืนมีผลกระทบต่อผลลพัธ์ของการใชย้าน้ีของท่านหรือไม่ ທ່ານຄິດວ່າການໃຊູ້ຢານີົ້ຂອງຄົນອ ື່ນມີຜົນກະທົບກັບ
ສະມັດຖະພາບຂອງການໃຊູ້ຢານີົ້ຂອງທ່ານຫ  ບ ໍ່
Yes ใช่ ແມ່ນ .......................................... 1 
No ไม่ใช่ ບ ໍ່ແມ່ນ ....................................... 2 
I don’t know ไม่ทราบ ບ ໍ່ຮ ູ້ ......................... 99 
 
a. As I have said before, these survey questions are not intended to measure your knowledge. Did you feel 
tested or pressured being asked these questions at all? เราไดบ้อกท่านขา้งตน้เก่ียวกบัค าถามเหล่าน้ีท่ีไม่ไดถู้กออกแบบเพื่อเป็น
ขอ้สอบวดัความรู้ ท่านรู้สึกถูกทดสอบหรือกดดนัในการตอบค าถามเหล่าน้ีหรือไม่ ເຮົາໄດູ້ບອກທ່ານຂັົ້ນຕົົ້ນກ່ຽວກັບຄໍາຖາມເຫ ົັ່ານີົ້ທີື່ບ ໍ່ໄດູ້ອອກແບບ
ເພ ື່ອເປັນບົດເສັງວັດແທກຄວາມຮ ູ້ ທ່ານຮ ູ້ສຶກຖ ກທົດສອບຫ  ກົດດັນໃນການຕອບຄໍາຖາມເຫ ົັ່ານີົ້ຫ  ບ ໍ່
b. Have you heard of antibiotics? ท่านเคยไดย้ินเก่ียวกบัยาปฏิชีวนะหรือไม่ ທ່ານເຄີຍໄດູ້ຍິນກ່ຽວກັບຢາຕູ້ານເຊ ົ້ອຫ  ບ ໍ່
c. Other than the term “antibiotics,” how do you normally call these medicines? นอกจากค าวา่ “ยาปฏิชีวนะ” ท่านเรียกยา
ชนิดน้ีไดว้า่อะไรอีกบา้ง ນອກຈາກຄໍາວ່າ ຢາຕູ້ານເຊ ົ້ອ ທ່ານເອີົ້ນຢາຊະນິດນີົ້ໄດູ້ວ່າຫຍັງອີກແດ່ 
d. Do you think other villagers will associate the pictures with other types of medicine? ท่านคิดวา่ชาวบา้นคนอ่ืนๆ จะ
นึกถึงยาชนิดอ่ืนหรือไม่เม่ือเห็นภาพเหล่าน้ี ທ່ານຄິດວ່າຊາວບູ້ານຄົນອ ື່ນໆ ຈະນຶກເຖິງຢາຊະນິດອ ື່ນຫ  ບ ໍ່ເມ ື່ອເຫັນພາບເຫ ົັ່ານີົ້ 
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Part V – Household-Related Survey Questions ส่วนที ่5 – ค าถามเกีย่วกบัครัวเรือน ສວ່ນທີື່ 5 - ຄາໍຖາມກຽ່ວກບັຄວົເຮ ອນ 
Thank you. We now come to the last part. ขอบคุณครับ/ค่ะ ส่วนต่อไปเป็นส่วนสุดทา้ยของการสมัภาษณ์ ຂອບໃຈ ສ່ວນຕ ໍ່ເປັນເປັນສ່ວນສຸດທູ້າຍຂອງ
ການສໍາພາດ 
 
11. The following questions relate to your household. ค าถามต่อไปน้ีเป็นค าถามเก่ียวกบัครัวเรือนของท่าน ຄໍາຖາມຕ ໍ່ໄປນີົ້ເປັນຄໍາຖາມກ່ຽວກັບ
ຄົວເຮ ອນຂອງທ່ານ 
I will now ask 
you for some 



















Have you got a functioning radio in your household? If so, how many?  ท่านมีวทิยุท่ีใชง้านไดอ้ยูใ่น
ครัวเรือนของท่านหรือไม่ ถา้มี ก่ีเคร่ือง ທ່ານມີວທິະຍຸທີື່ໃຊູ້ງານໄດູ້ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກອັນ _______ 
Have you got a functioning TV in your household? If so, how many? ท่านมีโทรทัศน์ท่ีใชง้านไดอ้ยูใ่น
ครัวเรือนของท่านหรือไม่ ถา้มี ก่ีเคร่ือง ທ່ານມີທ ລະທດັທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກອັນ _______ 
Have you got a functioning rice cooker in your household? If so, how many? ท่านมีหม้อหุงข้าวท่ี
ใชง้านไดอ้ยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีเคร่ือง ທ່ານມີໝໍໍ້ຫຸງເຂົົ້າທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກອັນ _______ 
Have you got a functioning landline telephone in your household? If so, how many? ท่านมี
โทรศัพท์บ้านท่ีใชง้านไดอ้ยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีเคร่ือง ທ່ານມີໂທລະສບັຕັົ້ງໂຕະທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່
ຖູ້າມີ ຈັກອັນ _______ 
Have you got a functioning mobile phone in your household? If so, how many? ท่านมี
โทรศัพท์มือถือท่ีใชง้านไดอ้ยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีเคร่ือง ທ່ານມີໂທລະສບັມ ຖ ທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່
ຖູ້າມີ ຈັກອັນ _______ 
Have you got a functioning computer in your household? If so, how many? ท่านมีคอมพวิเตอร์ท่ีใช้
งานไดอ้ยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีเคร่ือง ທ່ານມີຄອມພວິເຕີທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກອັນ _______ 
Have you got a functioning bicycle in your household? If so, how many? ท่านมีรถจกัรยานท่ีใชง้านได้
อยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีคนั ທ່ານມີລດົຖບີທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກຄັນ _______ 
Have you got a functioning scooter, motorcycle, or tricycle in your household? If so, how 
many? ท่านมีจกัรยานยนต์หรือรถสามล้อท่ีใชง้านไดอ้ยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีคนั ທ່ານມີລດົຈກັຫ  ລດົສາມລ ໍ້ທີື່ໃຊູ້ງານໄດູ້ຢ ູ່
ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກຄັນ _______ 
Have you got a functioning car or truck in your household? If so, how many? ท่านมีรถยนต์ รถ
กระบะ หรือรถบรรทุกท่ีใชง้านไดอ้ยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีคนั ທ່ານມີລດົໃຫ່ຍ ລດົກະບະ ຫ  ລດົບນັທກຸທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນ
ຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກຄັນ _______ 
Have you got a functioning tractor in your household? If so, how many? ท่านมีรถแทรกเตอร์หรือรถไถ
นาท่ีใชง้านไดอ้ยูใ่นครัวเรือนของท่านหรือไม่ ถา้มี ก่ีคนั ທ່ານມີລົດໄຖນາທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່ ຖູ້າມີ ຈັກຄັນ _______ 
Have you got a functioning refrigerator or freezer in your household? If so, how many? ท่าน
มีตู้เย็นหรือตู้แช่เข็งท่ีใชง้านไดอ้ยูใ่นครัวเรือนของทา่นหรือไม่ ถา้มี ก่ีตู ้ທ່ານມີຕ ູ້ເຢັນຫ  ຕ ູ້ແຊແ່ຂງທີື່ໃຊູ້ງານໄດູ້ຢ ູ່ໃນຄົວເຮ ອນຂອງທ່ານຫ  
ບ ໍ່ ຖູ້າມີ ຈັກຕ ູ້ _______ 
 
a. Do you feel comfortable (or uncomfortable) recalling these points for your household?  
ท่านรู้สึกสบายใจ (หรืออึดอดัใจ) ในการนึกถึงขา้วของเคร่ืองใชเ้หล่าน้ีในครัวเรือนของท่านหรือไม่ ທ່ານຮ ູ້ສຶກສະບາຍໃຈ (ຫ  ອິດອັດໃຈ) ໃນການນຶກເຖິງ
ເຄ ື່ອງໃຊູ້ເຫ ົັ່ານີົ້ໃນຄົວເຮ ອນຂອງທ່ານຫ  ບ ໍ່
b. Are there some common household items that you normally see in your village? 
ขา้วของเคร่ืองใชท่ี้เรากล่าวมาขา้งตน้เป็นส่ิงท่ีคนในหมู่บา้นน้ีใชก้นัทัว่ไปหรือไม่ ເຄ ື່ອງໃຊູ້ທີື່ເຮົາກ່າວມາໃນຂັົ້ນຕົົ້ນເປັນສິື່ງທີື່ຄົນໃນໝ ່ບູ້ານນີົ້ໃຊູ້ທົັ່ວໄປ
ຫ  ບ ໍ່
c. How would you distinguish whether somebody in your village is wealthy or not? 
OxTREC reference: 528-17 ANTIBIOTICS AND ACTIVITY SPACES 
20 June 2017. Version No: 2.0                                        Page 17 of 17 
ในหมู่บา้นของท่าน ท่านสามารถแยกไดอ้ยา่งไรวา่ใครรวยหรือจน ໃນໝ ່ບູ້ານຂອງທ່ານ ທ່ານສາມາດແຍກໄດູ້ແນວໃດວ່າໃຜລວຍຫ  ທຸກ  
d. If you had to group these houses into 2 categories, rich and poor, how would you do that? [Sample 
pictures will be provided] หากท่านตอ้งจดักลุ่มบา้นในภาพเหล่าน้ีออกเป็นสองกลุ่ม ไดแ้ก่กลุ่มรวยและกลุ่มจน ท่านจะจดัอยา่งไร [แสดงบตัรภาพ
ใหผู้ใ้หส้มัภาษณจ์ดักลุ่ม] ຫາກທ່ານຕູ້ອງຈັດກຸ່ມເຮ ອນໃນຮ ບເຫ ົັ່ານີົ້ອອກເປັນສອງກຸ່ມໄດູ້ແກ່ກຸ່ມລວຍແລະກຸ່ມທຸກ ທ່ານຈະຈັດແນວໃດ 
[ສະແດງບັດພາບໃຫູ້ຜ ູ້ສໍາພາດຈັດກຸ່ມ] 
e. What kinds of “meals” did you have in mind when you answered the question? 
ตอนท่ีท่านตอบค าถามเราเร่ืองม้ืออาหารท่ีท่านรับประทานสัปดาห์ท่ีแลว้ ท่านจินตนาการภาพถึงม้ืออาหารลกัษณะใด ຕອນທ່ານຕອບຄໍາຖາມເຮົາເລ ື່ອງຄາບ
ອາຫານທີື່ທ່ານກິນໃນອາທິດທີື່ແລູ້ວ ທ່ານຈິນຕະການການພາບເຖິງຄາບອາຫານລັກຊະນະໃດ 
 
12. And these are the last two questions. I would like to ask you once more to share your thoughts as you answer 
these questions. และค าถามสองค าถามสุดทา้ย เราตอ้งการขอใหท่้านเล่าใหเ้ราฟังอีกคร้ังวา่ท่านคิดอะไรบา้งระหวา่งการตอบค าถามต่อไปน้ี ແລະຄໍາຖາມສອງຄໍາ
ຖາມສຸດທູ້າຍ ເຮົາຂ ໃຫູ້ທ່ານເລົັ່າໃຫູ້ເຮົາຟັງອີກເທ ື່ອໜຶື່ງວ່າທ່ານຄິດຫຍັງແດ່ລະຫ່ວາງການຕອບຄໍາຖາມເຫ ົັ່ານີົ້ 
 
And finally the last two questions: Have you heard about drug resistance? 
ค าถามสองขอ้สุดทา้ย: ท่านเคยไดย้นิเก่ียวกบัการด้ือยาหรือไม่ ຄໍາຖາມສອງຂ ໍ້ສຸດທູ້າຍ: ທ່ານເຄີຍໄດູ້ຍິນກ່ຽວກັບການ
ດ ົ້ຢາຫ  ບ ໍ່
Yes เคย ເຄີຍ........................................... 1 
No ไม่เคย ບ ໍ່ເຄີຍ ....................................... 2 
 
What do you think is drug resistance? ท่านคิดวา่
การด้ือยาคืออะไร ທ່ານຄິດວ່າການດ ົ້ຢາແມ່ນຫຍັງ 
 
Answer relates to antibiotic or antimicrobial resistance ค าตอบสอดคลอ้งกบัการด้ือยา
ตา้นจุลชีพ ຄໍາຕອບສອດຄ່ອງກັບການດ ົ້ຢາຕູ້ານຈຸລະຊີບ .................................................. 1 
Answer relates to resistance to other types of drugs ค าตอบสอดคลอ้งกบัการด้ือยาชนิด
อ่ืนๆ ຄໍາຕອບສອງຄ່ອງກັບການດ ົ້ຢາຊະນິດອ ື່ນໆ ......................................................... 2 
Answer does not relate to drug resistance ค าตอบไม่สอดคลอ้งกบัการด้ือยา 
ຄໍາຕອບບ ໍ່ສອດຄ່ອງກັບການດ ົ້ຢາ .......................................................................... 3 
“Don’t know” ไม่ทราบ ບ ໍ່ຮ ູົ້ .............................................................................. 99 
 
a. What your intuitive understanding of “drug resistance?” เม่ือพูดถึง “การด้ือยา” ท่านเขา้ใจความหมายของค าค  าน้ีอยา่งไร ເມ ື່ອ
ເວົົ້າເຖິງ “ການດ ົ້ຢາ” ທ່ານເຂົົ້າໃຈຄວາມໝາຍຂອງຄໍານີົ້ແນວໃດ 
b. Do you think other villagers will translate the meaning of “drug resistance” differently from you? ท่านคิดวา่
ชาวบา้นคนอ่ืนๆ จะแปลความหมายของค าวา่ “ด้ือยา” แตกต่างจากท่านหรือไม่ ທ່ານຄດິວ່າຊາວບູ້ານຄົນອ ື່ນ ຈະແປຄວາມໝາຍຂອງຄໍາວ່າ “ດ ົ້
ຢາ” ແຕກຕ່າງຈາກທ່ານຫ  ບ ໍ່
c. Did you feel pressured answering these questions? ท่านรู้สึกกดดนัในการตอบค าถามน้ีหรือไม่ ທ່ານຮ ູ້ສຶກກົດດນັໃນການ
ຕອບຄໍາຖາມເຫ ົັ່ານີົ້ຫ  ບ ໍ່
 
We are coming to the end of our interview. Thank you so much for sharing your views with me. Your responses 
have been very helpful. การสัมภาษณ์นีส้ิ้นสุดลงแล้ว ค าตอบท่ีท่านให้กับเราเป็นประโยชน์กับการวิจัยของเราอย่างมาก ขอบคุณส าหรับความคิดเห็นท่ีท่านแบ่งปัน
กับเรา ການສໍາພາດນີົ້ສີົ້ນສຸດແລູ້ວ ຄໍາຕອບທີື່ທ່ານໃຫູ້ກັບເຮົາຈະເປັນປະໂຫຍດກັບການຄົົ້ນຄູ້ວາຂອງເຮົາຫ າຍ ຂອບໃຈສໍາລັບຄໍາຄິດເຫັນທີື່
ທ່ານແບ່ງປັນກັບເຮົາ 
